BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Shea RS, Dasarathy S, McCullough AJ;  Practice Guideline Committee of the American Association for the Study of Liver Diseases;  Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2010;51:307-328. [PMID: 20034030 DOI: 10.1002/hep.23258] [Cited by in Crossref: 750] [Cited by in F6Publishing: 664] [Article Influence: 62.5] [Reference Citation Analysis]
Number Citing Articles
1 Owens RE, Snyder HS, Twilla JD, Satapathy SK. Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification. J Clin Exp Hepatol 2016;6:275-81. [PMID: 28003716 DOI: 10.1016/j.jceh.2016.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pauly B, Brown M, Chow C, Wettlaufer A, Graham B, Urbanoski K, Callaghan R, Rose C, Jordan M, Stockwell T, Thomas G, Sutherland C; East Side Illicit Drinkers Group for Education (EIDGE). "If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs. Harm Reduct J 2021;18:65. [PMID: 34162375 DOI: 10.1186/s12954-021-00512-5] [Reference Citation Analysis]
3 Robert S, Gicquel T, Bodin A, Lagente V, Boichot E. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells. PLoS One 2016;11:e0153118. [PMID: 27046197 DOI: 10.1371/journal.pone.0153118] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
4 Trépo E, Goossens N, Fujiwara N, Song WM, Colaprico A, Marot A, Spahr L, Demetter P, Sempoux C, Im GY, Saldarriaga J, Gustot T, Devière J, Thung SN, Minsart C, Sersté T, Bontempi G, Abdelrahman K, Henrion J, Degré D, Lucidi V, Rubbia-Brandt L, Nair VD, Moreno C, Deltenre P, Hoshida Y, Franchimont D. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. Gastroenterology 2018;154:965-75. [PMID: 29158192 DOI: 10.1053/j.gastro.2017.10.048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
5 Casanova J, Bataller R. Alcoholic hepatitis: Prognosis and treatment. Gastroenterol Hepatol. 2014;37:262-268. [PMID: 24656653 DOI: 10.1016/j.gastrohep.2014.02.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
6 Latchoumycandane C, Hanouneh M, Nagy LE, McIntyre TM. Inflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption. PLoS One 2015;10:e0145691. [PMID: 26720402 DOI: 10.1371/journal.pone.0145691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
7 Fuster D, Garcia-Calvo X, Zuluaga P, Rivas I, Sanvisens A, Tor J, Muga R. Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Drug Alcohol Depend. 2018;190:195-199. [PMID: 30048873 DOI: 10.1016/j.drugalcdep.2018.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Karatayli E, Hall RA, Weber SN, Dooley S, Lammert F. Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury. Biochim Biophys Acta Mol Basis Dis 2019;1865:298-307. [PMID: 30447270 DOI: 10.1016/j.bbadis.2018.11.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
9 Peng JH, Cui T, Sun ZL, Huang F, Chen L, Xu L, Feng Q, Hu YY. Effects of Puerariae Radix Extract on Endotoxin Receptors and TNF-α Expression Induced by Gut-Derived Endotoxin in Chronic Alcoholic Liver Injury. Evid Based Complement Alternat Med. 2012;2012:234987. [PMID: 23133491 DOI: 10.1155/2012/234987] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
10 Zhang P, Meng L, Song L, Du J, Du S, Cui W, Liu C, Li F. Roles of Perilipins in Diseases and Cancers. Curr Genomics 2018;19:247-57. [PMID: 29755288 DOI: 10.2174/1389202918666170915155948] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
11 Chayanupatkul M, Liangpunsakul S. Alcoholic hepatitis: A comprehensive review of pathogenesis and treatment. World J Gastroenterol 2014; 20(20): 6279-6286 [PMID: 24876748 DOI: 10.3748/wjg.v20.i20.6279] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
12 Kesar V, Odin JA. Toll-like receptors and liver disease. Liver Int 2014;34:184-96. [DOI: 10.1111/liv.12315] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
13 Allampati S, Mullen KD. Long-Term Management of Alcoholic Liver Disease. Clinics in Liver Disease 2016;20:551-62. [DOI: 10.1016/j.cld.2016.02.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Hasse JM, DiCecco SR. Enteral Nutrition in Chronic Liver Disease: Translating Evidence Into Practice. Nutr Clin Pract 2015;30:474-87. [PMID: 26113562 DOI: 10.1177/0884533615591058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
15 Haim-boukobza S, Coilly A, Sebagh M, Bouamoud M, Antonini T, Roche B, Yordanova O, Savary J, Saliba F, Duclos-vallee J, Samuel D, Ichai P, Roque-afonso A. Hepatitis E infection in patients with severe acute alcoholic hepatitis. Liver Int 2015;35:870-5. [DOI: 10.1111/liv.12610] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
16 Li H, Qiu P, Wang J, Niu C, Pan S. Effects of compound Ginkgo biloba on intestinal permeability in rats with alcohol-induced liver injury. Food Funct 2015;6:470-8. [DOI: 10.1039/c4fo00739e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, Neuman MG, Rehm J. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2019;114:1574-86. [PMID: 31464740 DOI: 10.14309/ajg.0000000000000340] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
18 Lee SB, Park GM, Lee JY, Lee BU, Park JH, Kim BG, Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee HC. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. J Hepatol. 2018;68:1018-1024. [PMID: 29274406 DOI: 10.1016/j.jhep.2017.12.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
19 Lestari N, Louisa M, Soetikno V, Suwana AG, Ramadhan PA, Akmal T, Arozal W. Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 Pathways. J Toxicol 2018;2018:5360496. [PMID: 30538742 DOI: 10.1155/2018/5360496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Potts JR, Goubet S, Heneghan MA, Verma S. Determinants of long-term outcome in severe alcoholic hepatitis. Aliment Pharmacol Ther 2013;38:584-95. [PMID: 23879720 DOI: 10.1111/apt.12427] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 8.2] [Reference Citation Analysis]
21 Puri P, Thursz M. Intensive Enteral Nutrition in Alcoholic Hepatitis: More Food for Thought. Gastroenterology 2016;150:803-5. [PMID: 26924095 DOI: 10.1053/j.gastro.2016.02.061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
22 Sun J, Fu J, Li L, Chen C, Wang H, Hou Y, Xu Y, Pi J. Nrf2 in alcoholic liver disease. Toxicol Appl Pharmacol. 2018;357:62-69. [PMID: 30165058 DOI: 10.1016/j.taap.2018.08.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
23 Sun J, Fu J, Zhong Y, Li L, Chen C, Wang X, Wang L, Hou Y, Wang H, Zhao R, Zhang X, Yamamoto M, Xu Y, Pi J. NRF2 mitigates acute alcohol-induced hepatic and pancreatic injury in mice. Food Chem Toxicol 2018;121:495-503. [PMID: 30248482 DOI: 10.1016/j.fct.2018.09.042] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
24 Reardon J, Hussaini T, Alsahafi M, Azalgara VM, Erb SR, Partovi N, Yoshida EM. Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review. J Clin Transl Hepatol. 2016;4:192-205. [PMID: 27777888 DOI: 10.14218/jcth.2016.00023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
25 Zakaria Z, Othman ZA, Suleiman JB, Che Jalil NA, Ghazali WSW, Nna VU, Mohamed M. Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. Antioxidants (Basel) 2021;10:2031. [PMID: 34943134 DOI: 10.3390/antiox10122031] [Reference Citation Analysis]
26 Parés A, Mas A. Extracorporeal liver support in severe alcoholic hepatitis. World J Gastroenterol 2014; 20(25): 8011-8017 [PMID: 25009371 DOI: 10.3748/wjg.v20.i25.8011] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
27 Jiang Z, Wang J, Xue H, Wang M, Jiang H, Liang Y, Dias AC, Gregory M, Chen C, Zhang X. Protective effect of wild Corni fructus methanolic extract against acute alcoholic liver injury in mice. Redox Rep 2017;22:338-45. [PMID: 27712564 DOI: 10.1080/13510002.2016.1239867] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
28 Oeda S, Takahashi H, Yoshida H, Ogawa Y, Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, Fujii H, Nishino K, Sumida Y, Tanaka S, Kawanaka M, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Prevalence of pruritus in patients with chronic liver disease: A multicenter study: Pruritus in chronic liver disease. Hepatol Res 2018;48:E252-62. [DOI: 10.1111/hepr.12978] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
29 Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, Choi BI, Wilson SR, Kudo M, Barr RG. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound Med Biol. 2018;44:2419-2440. [PMID: 30209008 DOI: 10.1016/j.ultrasmedbio.2018.07.008] [Cited by in Crossref: 152] [Cited by in F6Publishing: 110] [Article Influence: 38.0] [Reference Citation Analysis]
30 Karlas T, Petroff D, Garnov N, Böhm S, Tenckhoff H, Wittekind C, Wiese M, Schiefke I, Linder N, Schaudinn A. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS One. 2014;9:e91987. [PMID: 24637477 DOI: 10.1371/journal.pone.0091987] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 10.0] [Reference Citation Analysis]
31 Yang J, Syed F, Xia Y, Sanyal AJ, Shah VH, Chalasani N, Zheng X, Yu Q, Lou Y, Li W. Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3α and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis. Alcohol Clin Exp Res 2021;45:720-31. [PMID: 33587293 DOI: 10.1111/acer.14579] [Reference Citation Analysis]
32 Kong X, Feng D, Mathews S, Gao B. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol 2013;28 Suppl 1:56-60. [PMID: 23855297 DOI: 10.1111/jgh.12032] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
33 Liu SX, Du YC, Zeng T. A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects. Toxicol Res (Camb) 2021;10:523-30. [PMID: 34141166 DOI: 10.1093/toxres/tfab042] [Reference Citation Analysis]
34 Siddiqui MS, Charlton M. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management. Gastroenterology 2016;150:1849-62. [DOI: 10.1053/j.gastro.2016.02.077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
35 Vuittonet CL, Halse M, Leggio L, Fricchione SB, Brickley M, Haass-Koffler CL, Tavares T, Swift RM, Kenna GA. Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm. 2014;71:1265-1276. [PMID: 25027533 DOI: 10.2146/ajhp140028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
36 Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 2013;8:627-637. [PMID: 23449255 DOI: 10.1038/nprot.2013.032] [Cited by in Crossref: 443] [Cited by in F6Publishing: 439] [Article Influence: 49.2] [Reference Citation Analysis]
37 Li W, Amet T, Xing Y, Yang D, Liangpunsakul S, Puri P, Kamath PS, Sanyal AJ, Shah VH, Katz BP, Radaeva S, Crabb DW, Chalasani N, Yu Q. Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study. Hepatology 2017;66:575-90. [PMID: 28466561 DOI: 10.1002/hep.29242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
38 Yi SW, Choi JS, Yi JJ, Lee YH, Han KJ. Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea. Cancer. 2018;124:2748-2757. [PMID: 29669170 DOI: 10.1002/cncr.31406] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
39 Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology 2018;68:251-67. [DOI: 10.1016/j.jhep.2017.11.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 13.0] [Reference Citation Analysis]
40 Ahn SY, Kim SB, Song IH. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Can J Gastroenterol Hepatol 2020;2020:4873875. [PMID: 32566546 DOI: 10.1155/2020/4873875] [Reference Citation Analysis]
41 Kahali B, Halligan B, Speliotes EK. Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2015;35:375-91. [PMID: 26676813 DOI: 10.1055/s-0035-1567870] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
42 Sprague Martinez L, Walter AW, Acevedo A, López LM, Lundgren L. Context Matters: Health Disparities in Substance Use Disorders and Treatment. Journal of Social Work Practice in the Addictions 2018;18:84-98. [DOI: 10.1080/1533256x.2017.1412979] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
43 Byun JS, Jeong WI. Involvement of hepatic innate immunity in alcoholic liver disease. Immune Netw. 2010;10:181-187. [PMID: 21286378 DOI: 10.4110/in.2010.10.6.181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
44 Peiyuan H, Zhiping H, Chengjun S, Chunqing W, Bingqing L, Imam MU. Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress. Evid Based Complement Alternat Med 2017;2017:4287890. [PMID: 29456571 DOI: 10.1155/2017/4287890] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
45 Yang S, Wu K, Wang J, Lee C, Kuo Y, Tai W, Chen C, Chiou S, Lu S, Hu T, Changchien C, Chuah S. The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions. Hepatol Int 2013;7:257-67. [DOI: 10.1007/s12072-012-9378-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
46 D’Souza El-Guindy NB, Kovacs EJ, De Witte P, Spies C, Littleton JM, de Villiers WJ, Lott AJ, Plackett TP, Lanzke N, Meadows GG. Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model. Alcohol Clin Exp Res. 2010;34:1489-1511. [PMID: 20586763 DOI: 10.1111/j.1530-0277.2010.01234.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
47 Manley S, Ding W. Role of farnesoid X receptor and bile acids in alcoholic liver disease. Acta Pharm Sin B. 2015;5:158-167. [PMID: 26579442 DOI: 10.1016/j.apsb.2014.12.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
48 Rausch V, Peccerella T, Lackner C, Yagmur E, Seitz HK, Longerich T, Mueller S. Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M. World J Hepatol 2016; 8(35): 1547-1556 [PMID: 28050235 DOI: 10.4254/wjh.v8.i35.1547] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
49 Wellhöner F, Döscher N, Woelfl F, Vital M, Plumeier I, Kahl S, Potthoff A, Manns MP, Pieper DH, Cornberg M, Wedemeyer H, Heidrich B. Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis. Hepatology 2021;74:72-82. [PMID: 33411981 DOI: 10.1002/hep.31700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 M C C C, N L L, C M F, J L G, D A, C G, G C, S H P, C M, F S M. Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota. BMC Microbiol. 2014;14:240. [PMID: 25223989 DOI: 10.1186/s12866-014-0240-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
51 Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S. Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2011;300:G516-G525. [PMID: 21252049 DOI: 10.1152/ajpgi.00537.2010] [Cited by in Crossref: 134] [Cited by in F6Publishing: 138] [Article Influence: 12.2] [Reference Citation Analysis]
52 Park KH, Kim SH. Low dose of chronic ethanol exposure in adult zebrafish induces hepatic steatosis and injury. Biomed Pharmacother 2019;117:109179. [PMID: 31387182 DOI: 10.1016/j.biopha.2019.109179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
53 Ong SY, Nicoll AJ, Delatycki MB. How should hyperferritinaemia be investigated and managed? European Journal of Internal Medicine 2016;33:21-7. [DOI: 10.1016/j.ejim.2016.05.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
54 Vatsalya V, Cave MC, Kong M, Gobejishvili L, Falkner KC, Craycroft J, Mitchell M, Szabo G, McCullough A, Dasarathy S, Radaeva S, Barton B, McClain CJ. Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020;18:2046-54. [PMID: 31811953 DOI: 10.1016/j.cgh.2019.11.050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
55 Shukla I, Azmi L, Gupta SS, Upreti DK, Rao CV. Amelioration of anti-hepatotoxic effect by Lichen rangiferinus against alcohol induced liver damage in rats. J Ayurveda Integr Med 2019;10:171-7. [PMID: 29395895 DOI: 10.1016/j.jaim.2017.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Ren J, Lu Y, Qian Y, Chen B, Wu T, Ji G. Recent progress regarding kaempferol for the treatment of various diseases. Exp Ther Med 2019;18:2759-76. [PMID: 31572524 DOI: 10.3892/etm.2019.7886] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
57 Shrestha UK, Sapkota S. Etiology and adverse outcome predictors of upper gastrointestinal bleeding in 589 patients in Nepal. Dig Dis Sci. 2014;59:814-822. [PMID: 24282053 DOI: 10.1007/s10620-013-2946-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
58 Bang HA, Kwon YH, Lee MJ, Lee WC. Trends in the epidemiological aspects and mortality of alcoholic liver disease in Korea in the decade between 2000 and 2009. J Clin Med Res 2015;7:91-6. [PMID: 25436025 DOI: 10.14740/jocmr1975e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
59 Zhou C, Zhang N, He TT, Wang Y, Wang LF, Sun YQ, Jing J, Zhang JJ, Fu SN, Wang X, Liang XX, Li X, Gong M, Li J. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(30): 4479-4488 [PMID: 32874059 DOI: 10.3748/wjg.v26.i30.4479] [Reference Citation Analysis]
60 Louvet A. Prednisolone vs. pentoxifylline for severe alcoholic hepatitis. J Hepatol 2014;61:723-4. [PMID: 25014637 DOI: 10.1016/j.jhep.2014.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
61 Souza NP, Villar LM, Garbin AJ, Rovida TA, Garbin CA. Assessment of health-related quality of life and related factors in patients with chronic liver disease. Braz J Infect Dis 2015;19:590-5. [PMID: 26361840 DOI: 10.1016/j.bjid.2015.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
62 Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, Davies S, Bateman A, Sheron N, Allison M, Alexander GJ. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS One 2013;8:e72904. [PMID: 24086266 DOI: 10.1371/journal.pone.0072904] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
63 Iida-Ueno A, Enomoto M, Tamori A, Kawada N. Hepatitis B virus infection and alcohol consumption. World J Gastroenterol 2017; 23(15): 2651-2659 [PMID: 28487602 DOI: 10.3748/wjg.v23.i15.2651] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
64 Liu Q, Xu L, Wu M, Zhou Y, Yang J, Huang C, Xu T, Li J, Zhang L. Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy. Cell Biosci 2021;11:129. [PMID: 34246287 DOI: 10.1186/s13578-021-00622-4] [Reference Citation Analysis]
65 Chen R, Xu L, Du S, Huang S, Wu H, Dong J, Huang J, Wang X, Feng W, Chen Y. Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances T reg and T H 17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding. Toxicology Letters 2016;241:103-10. [DOI: 10.1016/j.toxlet.2015.11.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
66 Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S. Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2011;300:G516-G525. [PMID: 21252049 DOI: 10.1152/ajpqi.00537.2010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Wang HG, Wang LZ, Fu HJ, Shen P, Huang XD, Zhang FM, Xie R, Yang XZ, Ji GZ. Cholecystectomy does not significantly increase the risk of fatty liver disease. World J Gastroenterol 2015; 21(12): 3614-3618 [PMID: 25834328 DOI: 10.3748/wjg.v21.i12.3614] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
68 Rudler M, Mouri S, Charlotte F, Cluzel P, Ngo Y, Munteanu M, Lebray P, Ratziu V, Thabut D, Poynard T. Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis. PLoS One 2015;10:e0134302. [PMID: 26252713 DOI: 10.1371/journal.pone.0134302] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
69 Goyal SK, Dixit VK, Jain AK, Mohapatra PK, Ghosh JK. Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis. J Clin Exp Hepatol. 2014;4:19-24. [PMID: 25755531 DOI: 10.1016/j.jceh.2014.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
70 Chang RC, Wang H, Bedi Y, Golding MC. Preconception paternal alcohol exposure exerts sex-specific effects on offspring growth and long-term metabolic programming. Epigenetics Chromatin 2019;12:9. [PMID: 30670059 DOI: 10.1186/s13072-019-0254-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
71 Sohail U, Satapathy SK. Diagnosis and management of alcoholic hepatitis. Clin Liver Dis. 2012;16:717-736. [PMID: 23101979 DOI: 10.1016/j.cld.2012.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
72 Rua RM, Ojeda ML, Nogales F, Rubio JM, Romero-Gómez M, Funuyet J, Murillo ML, Carreras O. Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol. Life Sci. 2014;94:158-163. [PMID: 24157457 DOI: 10.1016/j.lfs.2013.10.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
73 Sidhu SS, Goyal O, Kishore H, Sidhu S. New paradigms in management of alcoholic hepatitis: a review. Hepatol Int 2017;11:255-67. [PMID: 28247264 DOI: 10.1007/s12072-017-9790-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
74 Lemasters JJ. Hepatotoxicity Due to Mitochondrial Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 85-100. [DOI: 10.1016/b978-0-12-387817-5.00005-4] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
75 Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010;52:1291-300. [PMID: 20842630 DOI: 10.1002/hep.23837] [Cited by in Crossref: 271] [Cited by in F6Publishing: 268] [Article Influence: 22.6] [Reference Citation Analysis]
76 Zhang T, Li J, Liu CP, Guo M, Gao CL, Zhou LP, Long Y, Xu Y. Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis. Ann Transl Med 2021;9:873. [PMID: 34164507 DOI: 10.21037/atm-21-2158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Sutoh Y, Hachiya T, Suzuki Y, Komaki S, Ohmomo H, Kakisaka K, Wang T, Takikawa Y, Shimizu A. ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis. Sci Rep 2020;10:16227. [PMID: 33004991 DOI: 10.1038/s41598-020-73263-1] [Reference Citation Analysis]
78 Pateria P, de Boer B, MacQuillan G. Liver abnormalities in drug and substance abusers. Best Pract Res Clin Gastroenterol. 2013;27:577-596. [PMID: 24090944 DOI: 10.1016/j.bpg.2013.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
79 Gao B, Zhu Y, Gao N, Shen W, Stärkel P, Schnabl B. Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. Metabolites 2021;11:766. [PMID: 34822424 DOI: 10.3390/metabo11110766] [Reference Citation Analysis]
80 Furuichi Y, Abe M, Kasai Y, Takeuchi H, Yoshimasu Y, Itoi T. Secure intravariceal sclerotherapy with red dichromatic imaging decreases the recurrence rate of esophageal varices: A propensity score matching analysis. J Hepatobiliary Pancreat Sci 2021;28:431-42. [PMID: 33453078 DOI: 10.1002/jhbp.894] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Wang Z, Wu X, Zhang Y, Zhou L, Li L, Yu Y, Wang L. Discrepant roles of CpG ODN on acute alcohol-induced liver injury in mice. Int Immunopharmacol 2012;12:526-33. [PMID: 22293535 DOI: 10.1016/j.intimp.2012.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
82 Jiménez-Sousa MÁ, Gómez-Moreno AZ, Pineda-Tenor D, Brochado-Kith O, Sánchez-Ruano JJ, Artaza-Varasa T, Gómez-Sanz A, Fernández-Rodríguez A, Resino S. The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study. J Clin Med 2018;7:E473. [PMID: 30477195 DOI: 10.3390/jcm7120473] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
83 Li W, Xia Y, Yang J, Guo H, Sun G, Sanyal AJ, Shah VH, Lou Y, Zheng X, Chalasani N, Yu Q. Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis. Hepatol Commun 2020;4:588-605. [PMID: 32258953 DOI: 10.1002/hep4.1475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
84 Xiao J, Zhang R, Huang F, Liu L, Deng Y, Wei Z, Zhang Y, Liu D, Zhang M. The biphasic dose effect of lychee (Litchi chinensis Sonn.) pulp phenolic extract on alcoholic liver disease in mice. Food Funct 2017;8:189-200. [DOI: 10.1039/c6fo01166g] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
85 Correnti JM, Gottshall L, Lin A, Williams B, Oranu A, Beck J, Chen J, Bennett MJ, Carr RM. Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells. Sci Rep 2018;8:12923. [PMID: 30150688 DOI: 10.1038/s41598-018-31025-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
86 Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol. 2014;20:16443-16451. [PMID: 25469012 DOI: 0.3748/wjg.v20.i44.16443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Forsyth CB, Voigt RM, Burgess HJ, Swanson GR, Keshavarzian A. Circadian rhythms, alcohol and gut interactions. Alcohol. 2015;49:389-398. [PMID: 25499101 DOI: 10.1016/j.alcohol.2014.07.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
88 Potts JR, Verma S. Alcoholic hepatitis: diagnosis and management in 2012. Expert Rev Gastroenterol Hepatol. 2012;6:695-710. [PMID: 23237255 DOI: 10.1586/egh.12.57] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
89 Chang RC, Skiles WM, Chronister SS, Wang H, Sutton GI, Bedi YS, Snyder M, Long CR, Golding MC. DNA methylation-independent growth restriction and altered developmental programming in a mouse model of preconception male alcohol exposure. Epigenetics 2017;12:841-53. [PMID: 28816587 DOI: 10.1080/15592294.2017.1363952] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
90 Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano TD. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcohol Clin Exp Res. 2016;40:1390-1402. [PMID: 27254289 DOI: 10.1111/acer.13108] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
91 Carr RM, Peralta G, Yin X, Ahima RS. Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice. PLoS One. 2014;9:e97118. [PMID: 24831094 DOI: 10.1371/journal.pone.0097118] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 7.3] [Reference Citation Analysis]
92 Zhou JY, Jiang ZA, Zhao CY, Zhen Z, Wang W, Nanji AA. Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcohol Clin Exp Res. 2013;37:213-222. [PMID: 23009062 DOI: 10.1111/j.1530-0277.2012.01936.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
93 Karakike E, Moreno C, Gustot T. Infections in severe alcoholic hepatitis. Ann Gastroenterol 2017;30:152-60. [PMID: 28243035 DOI: 10.20524/aog.2016.0101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
94 Park MS, Hong S, Lim YL, Kang SH, Baik SK, Kim MY. Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study. Gut Liver 2018;12:555-61. [PMID: 29699059 DOI: 10.5009/gnl17342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
95 Ghosh Dastidar S, Warner JB, Warner DR, McClain CJ, Kirpich IA. Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration. Biomolecules 2018;8:E3. [PMID: 29342874 DOI: 10.3390/biom8010003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
96 Cuthbert JA, Arslanlar S, Yepuri J, Montrose M, Ahn CW, Shah JP. Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis. Dig Dis Sci 2014;59:1594-602. [PMID: 24445730 DOI: 10.1007/s10620-013-3020-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
97 Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012;122:3476-89. [PMID: 22945633 DOI: 10.1172/JCI60777] [Cited by in Crossref: 391] [Cited by in F6Publishing: 243] [Article Influence: 39.1] [Reference Citation Analysis]
98 Lucey MR. Liver transplantation for alcoholic liver disease. Nat Rev Gastroenterol Hepatol. 2014;11:300-307. [PMID: 24393837 DOI: 10.1038/nrgastro.2013.247] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 8.1] [Reference Citation Analysis]
99 Guo X, Wang Y, Shen Y, Gao Y, Chang Y, Duan X. Gene expression profiles of sodium-dependent vitamin C transporters in mice after alcohol consumption. Acta Biochim Biophys Sin (Shanghai) 2013;45:912-20. [PMID: 24080747 DOI: 10.1093/abbs/gmt099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
100 Testino G, Vignoli T, Patussi V, Scafato E, Caputo F; SIA board (Appendix A) and the external expert supervisors (Appendix B). Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA). Dig Liver Dis 2020;52:21-32. [PMID: 31757596 DOI: 10.1016/j.dld.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
101 Li B, Zhu L, Wu T, Zhang J, Jiao X, Liu X, Wang Y, Meng X. Effects of Triterpenoid From Schisandra chinensis on Oxidative Stress in Alcohol-Induced Liver Injury in Rats. Cell Biochem Biophys 2015;71:803-11. [DOI: 10.1007/s12013-014-0266-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
102 Mörs K, Kany S, Hörauf JA, Wagner N, Neunaber C, Perl M, Marzi I, Relja B. Suppression of the interleukin-1ß-induced inflammatory response of human Chang liver cells by acute and subacute exposure to alcohol: an in vitro study. Croat Med J 2018;59:46-55. [PMID: 29740988 DOI: 10.3325/cmj.2018.59.46] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
103 Schiavo L, Busetto L, Cesaretti M, Zelber-Sagi S, Deutsch L, Iannelli A. Nutritional issues in patients with obesity and cirrhosis. World J Gastroenterol 2018; 24(30): 3330-3346 [PMID: 30122874 DOI: 10.3748/wjg.v24.i30.3330] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
104 Ma HY, Xu J, Liu X, Zhu Y, Gao B, Karin M, Tsukamoto H, Jeste DV, Grant I, Roberts AJ, Contet C, Geoffroy C, Zheng B, Brenner D, Kisseleva T. The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease. Curr Pathobiol Rep 2016;4:27-35. [PMID: 27239399 DOI: 10.1007/s40139-016-0097-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
105 Campollo O. Alcohol and the Liver: The Return of the Prodigal Son. Ann Hepatol 2019;18:6-10. [PMID: 31113611 DOI: 10.5604/01.3001.0012.7854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Kedarisetty CK, Kumar A, Sarin SK. Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis. Semin Liver Dis 2021;41:67-78. [PMID: 33764486 DOI: 10.1055/s-0040-1719177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Almasio PL, Licata A, Maida M, Macaluso FS, Costantino A, Alessi N, Grimaudo S, Accardi G, Caruso C, Craxi A. Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort. Hepat Mon 2016;16:e31681. [PMID: 28070198 DOI: 10.5812/hepatmon.31681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
108 Mun J, Park J, Yoon HG, You Y, Choi KC, Lee YH, Kim K, Lee J, Kim OK, Jun W. Effects of Eriobotrya japonica Water Extract on Alcoholic and Nonalcoholic Fatty Liver Impairment. J Med Food 2019;22:1262-70. [PMID: 31834842 DOI: 10.1089/jmf.2019.4493] [Reference Citation Analysis]
109 Barve A, Marsano LS, Parajuli D, Cave M, Mcclain CJ. Alcoholic Liver Disease. In: Saeian K, Shaker R, editors. Liver Disorders. Cham: Springer International Publishing; 2017. pp. 173-97. [DOI: 10.1007/978-3-319-30103-7_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
110 Ambade A, Catalano D, Lim A, Kopoyan A, Shaffer SA, Mandrekar P. Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury. J Hepatol. 2014;61:903-911. [PMID: 24859453 DOI: 10.1016/j.jhep.2014.05.024] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
111 Fan R, Shan X, Qian H, Song C, Wu G, Chen Y, Miao Y, Cha W. Protective effect of apocynin in an established alcoholic steatohepatitis rat model. Immunopharmacology and Immunotoxicology 2012;34:633-8. [DOI: 10.3109/08923973.2011.648266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
112 Schwingel PA, Cotrim HP, Santos CR Jr, Santos AO, Andrade AR, Carruego MV, Zoppi CC. Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young Men. Subst Use Misuse 2015;50:1490-8. [PMID: 26549387 DOI: 10.3109/10826084.2015.1018550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
113 Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H. The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013;2013:495156. [PMID: 24385684 DOI: 10.1155/2013/495156] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 12.3] [Reference Citation Analysis]
114 Sahlman P, Nissinen M, Puukka P, Jula A, Salomaa V, Männistö S, Lundqvist A, Valsta L, Perola M, Färkkilä M, Åberg F. Genetic and lifestyle risk factors for advanced liver disease among men and women. Journal of Gastroenterology and Hepatology 2019;35:291-8. [DOI: 10.1111/jgh.14770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
115 Chiang DJ, McCullough AJ. The impact of obesity and metabolic syndrome on alcoholic liver disease. Clin Liver Dis. 2014;18:157-163. [PMID: 24274871 DOI: 10.1016/j.cld.2013.09.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
116 Wu X, Dong L, Lin X, Li J. Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease. Front Immunol 2017;8:1728. [PMID: 29312290 DOI: 10.3389/fimmu.2017.01728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
117 Kling CE, Perkins JD, Carithers RL, Donovan DM, Sibulesky L. Recent trends in liver transplantation for alcoholic liver disease in the United States. World J Hepatol 2017; 9(36): 1315-1321 [PMID: 29359014 DOI: 10.4254/wjh.v9.i36.1315] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
118 Niemelä O. Biomarker-Based Approaches for Assessing Alcohol Use Disorders. Int J Environ Res Public Health 2016;13:166. [PMID: 26828506 DOI: 10.3390/ijerph13020166] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
119 Ciocan D, Rebours V, Voican CS, Wrzosek L, Puchois V, Cassard AM, Perlemuter G. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. Sci Rep 2018;8:4822. [PMID: 29555983 DOI: 10.1038/s41598-018-23146-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
120 Agiasotelli D, Alexopoulou A, Vasilieva L, Kalpakou G, Papadaki S, Dourakis SP. Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event: Predictors of long-term survival in ACLF. Hepatol Res 2016;46:514-20. [DOI: 10.1111/hepr.12582] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
121 Fagan KJ, Irvine KM, McWhinney BC, Fletcher LM, Horsfall LU, Johnson LA, Clouston AD, Jonsson JR, O'Rourke P, Martin J, Pretorius CJ, Ungerer JP, Powell EE. BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin. Alcohol Clin Exp Res 2013;37:1771-8. [PMID: 23875541 DOI: 10.1111/acer.12143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
122 Vyhmeister R, Enestvedt CK. The Changing Liver Transplant Recipient: From Hepatitis C to Nonalcoholic Steatohepatitis and Alcohol. Clin Liver Dis 2021;25:137-55. [PMID: 33978575 DOI: 10.1016/j.cld.2020.08.012] [Reference Citation Analysis]
123 Fröhlich S, Murphy N, Kong T, Ffrench-o’carroll R, Conlon N, Ryan D, Boylan J. Alcoholic liver disease in the intensive care unit: Outcomes and predictors of prognosis. Journal of Critical Care 2014;29:1131.e7-1131.e13. [DOI: 10.1016/j.jcrc.2014.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
124 Bataller R, Rombouts K, Altamirano J, Marra F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Practice & Research Clinical Gastroenterology 2011;25:231-44. [DOI: 10.1016/j.bpg.2011.02.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
125 Yang JD, Kim B, Sanderson SO, St Sauver JL, Yawn BP, Pedersen RA, Larson JJ, Therneau TM, Roberts LR, Kim WR. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. Mayo Clin Proc 2012;87:9-16. [PMID: 22212963 DOI: 10.1016/j.mayocp.2011.07.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
126 Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R. Alcoholic hepatitis: The pivotal role of Kupffer cells. World J Gastrointest Pathophysiol 2015; 6(4): 90-98 [PMID: 26600966 DOI: 10.4291/wjgp.v6.i4.90] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
127 Forrest EH, Atkinson SR, Richardson P, Masson S, Ryder S, Thursz MR, Allison M. ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established. Am J Gastroenterol 2019;114:175-6. [PMID: 29887598 DOI: 10.1038/s41395-018-0076-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
128 Jiménez-Sousa MÁ, Gómez-Moreno AZ, Pineda-Tenor D, Medrano LM, Sánchez-Ruano JJ, Fernández-Rodríguez A, Artaza-Varasa T, Saura-Montalbán J, Vázquez-Morón S, Ryan P, Resino S. The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design. PLoS One 2018;13:e0197115. [PMID: 29742149 DOI: 10.1371/journal.pone.0197115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
129 Caballeria J. [Is there a role for pentoxifylline in the treatment of alcoholic hepatitis?]. Gastroenterol Hepatol 2016;39:560-5. [PMID: 26589540 DOI: 10.1016/j.gastrohep.2015.10.004] [Reference Citation Analysis]
130 Tampah-Naah AM, Amoah ST. Consumption and drinking frequency of alcoholic beverage among women in Ghana: a cross-sectional study. BMC Public Health 2015;15:317. [PMID: 25879511 DOI: 10.1186/s12889-015-1651-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
131 Holcomb VB, Hong J, Núñez NP. Exogenous estrogen protects mice from the consequences of obesity and alcohol. Menopause 2012;19:680-90. [PMID: 22228320 DOI: 10.1097/gme.0b013e31823cf6ee] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
132 Min BY, Kim NY, Jang ES, Shin CM, Lee SH, Park YS, Hwang JH, Jeong SH, Kim N, Lee DH, Kim JW. Ethanol potentiates hepatitis B virus replication through oxidative stress-dependent and -independent transcriptional activation. Biochem Biophys Res Commun. 2013;431:92-97. [PMID: 23274499 DOI: 10.1016/j.bbrc.2012.12.081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
133 Nam Y, Kim JH, Konkit M, Kim W. Hepatoprotective effects of Lactococcus chungangensis CAU 1447 in alcoholic liver disease. J Dairy Sci 2019;102:10737-47. [PMID: 31521345 DOI: 10.3168/jds.2019-16891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Shasthry SM, Rastogi A, Bihari C, Vijayaraghavan R, Arora V, Sharma MK, Sarin SK. Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis. Virchows Arch 2018;472:667-75. [DOI: 10.1007/s00428-018-2330-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
135 Ye M, Xu M, Ji C, Ji J, Ji F, Wei W, Yang S, Zhou B. Alterations in the Transcriptional Profile of the Liver Tissue and the Therapeutic Effects of Propolis Extracts in Alcohol-induced Steatosis in Rats. An Acad Bras Cienc 2019;91:e20180646. [PMID: 31411259 DOI: 10.1590/0001-3765201920180646] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Rausch V, Mueller S. Suppressed Fat Mobilization Due to PNPLA3 rs738409 -Associated Liver Damage in Heavy Drinkers: The Liver Damage Feedback Hypothesis. Adv Exp Med Biol 2018;1032:153-72. [PMID: 30362098 DOI: 10.1007/978-3-319-98788-0_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Mellinger JL, Fernandez A, Shedden K, Winder GS, Fontana RJ, Volk ML, Blow FC, Lok ASF. Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis. Alcohol Clin Exp Res 2019;43:334-41. [PMID: 30667521 DOI: 10.1111/acer.13944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
138 Maccioni L, Leclercq IA, Schnabl B, Stärkel P. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease. Int J Mol Sci 2021;22:12687. [PMID: 34884492 DOI: 10.3390/ijms222312687] [Reference Citation Analysis]
139 Vasques J, Guerreiro CS, Sousa J, Pinto M, Cortez-Pinto H. Nutritional support in cirrhotic patients with sarcopenia. Clin Nutr ESPEN 2019;33:12-7. [PMID: 31451247 DOI: 10.1016/j.clnesp.2019.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
140 Wang C, Ma C, Gong L, Dai S, Li Y. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Eur J Pharmacol 2021;912:174604. [PMID: 34743980 DOI: 10.1016/j.ejphar.2021.174604] [Reference Citation Analysis]
141 Hmoud BS, Patel K, Bataller R, Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int. 2016;36:721-728. [PMID: 26279269 DOI: 10.1111/liv.12939] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
142 Liu M, Dou Y, Sun R, Zhang Y, Liu Y. Molecular mechanisms for alcoholic hepatitis based on analysis of gene expression profile. Hepat Mon 2015;15:e27336. [PMID: 26045708 DOI: 10.5812/hepatmon.15(5)2015.27336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
143 Khirfan K, Hanson J, Alcorn J. Portal hypertension in alcoholic liver disease: can it be fixed? Dig Dis Sci 2015;60:838-40. [PMID: 25647760 DOI: 10.1007/s10620-015-3562-7] [Reference Citation Analysis]
144 Geldenhuys E, Burger EH, Alblas A, Greyling LM, Kotzé SH. The association between healed skeletal fractures indicative of interpersonal violence and alcoholic liver disease in a cadaver cohort from the Western Cape, South Africa. Alcohol 2016;52:41-8. [DOI: 10.1016/j.alcohol.2016.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
145 Poli A, Marangoni F, Avogaro A, Barba G, Bellentani S, Bucci M, Cambieri R, Catapano AL, Costanzo S, Cricelli C, de Gaetano G, Di Castelnuovo A, Faggiano P, Fattirolli F, Fontana L, Forlani G, Frattini S, Giacco R, La Vecchia C, Lazzaretto L, Loffredo L, Lucchin L, Marelli G, Marrocco W, Minisola S, Musicco M, Novo S, Nozzoli C, Pelucchi C, Perri L, Pieralli F, Rizzoni D, Sterzi R, Vettor R, Violi F, Visioli F. Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis 2013;23:487-504. [PMID: 23642930 DOI: 10.1016/j.numecd.2013.02.007] [Cited by in Crossref: 96] [Cited by in F6Publishing: 76] [Article Influence: 10.7] [Reference Citation Analysis]
146 Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012;32:902-10. [PMID: 22435761 DOI: 10.1111/j.1478-3231.2012.02781.x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 179] [Article Influence: 19.0] [Reference Citation Analysis]
147 Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Tor J, Muga R. Markers of inflammation and mortality in a cohort of patients with alcohol dependence. Medicine (Baltimore). 2015;94:e607. [PMID: 25761182 DOI: 10.1097/md.0000000000000607] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
148 Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol. 2012;56 Suppl 1:S39-S45. [PMID: 22300464 DOI: 10.1016/s0168-8278(12)60005-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
149 Agrawal S, Duseja A, Gupta T, Dhiman RK, Chawla Y. Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure. J Gastroenterol Hepatol. 2015;30:575-581. [PMID: 25251968 DOI: 10.1111/jgh.12778] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
150 Sugiyama A, Kurisu A, Ouoba S, E B, Ko K, Rakhimov A, Hussain MRA, Akita T, Harakawa T, Sako T, Koshiyama M, Tanaka J. Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008-2019. Liver Int 2021. [PMID: 34523235 DOI: 10.1111/liv.15055] [Reference Citation Analysis]
151 Fukuda T, Hamaguchi M, Osaka T, Hashimoto Y, Ushigome E, Asano M, Yamazaki M, Fukuda E, Yamaguchi K, Ogawa K, Goshima N, Fukui M. A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes. Molecules 2020;25:E1667. [PMID: 32260359 DOI: 10.3390/molecules25071667] [Reference Citation Analysis]
152 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
153 Suh YG, Jeong WI. Hepatic stellate cells and innate immunity in alcoholic liver disease. World J Gastroenterol 2011; 17(20): 2543-2551 [PMID: 21633659 DOI: 10.3748/wjg.v17.i20.2543] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
154 Tokushige K, Hashimoto E, Horie Y, Taniai M, Higuchi S. Hepatocellular carcinoma based on cryptogenic liver disease: The most common non-viral hepatocellular carcinoma in patients aged over 80 years: Cryptogenic HCC in the elderly. Hepatol Res 2015;45:441-7. [DOI: 10.1111/hepr.12372] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
155 Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:85-91. [PMID: 23451000 DOI: 10.3238/arztebl.2013.0085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
156 Lanthier N, Stärkel P. Treatment of severe alcoholic hepatitis: past, present and future. Eur J Clin Invest 2017;47:531-9. [PMID: 28517024 DOI: 10.1111/eci.12767] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
157 Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol. 2011;8:491-501. [PMID: 21826088 DOI: 10.1038/nrgastro.2011.134] [Cited by in Crossref: 178] [Cited by in F6Publishing: 162] [Article Influence: 16.2] [Reference Citation Analysis]
158 Phillips PK, Lucey MR. Acute Alcoholic Hepatitis: Therapy. Clin Liver Dis 2016;20:509-19. [PMID: 27373613 DOI: 10.1016/j.cld.2016.02.015] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
159 Suk KT, Kim MY, Baik SK. Alcoholic liver disease: Treatment. World J Gastroenterol 2014; 20(36): 12934-12944 [PMID: 25278689 DOI: 10.3748/wjg.v20.i36.12934] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
160 Moreno C, Deltenre P, Senterre C, Louvet A, Gustot T, Bastens B, Hittelet A, Piquet M, Laleman W, Orlent H, Lasser L, Sersté T, Starkel P, De Koninck X, Negrin Dastis S, Delwaide J, Colle I, de Galocsy C, Francque S, Langlet P, Putzeys V, Reynaert H, Degré D, Trépo E. Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids. Gastroenterology 2016;150:903-910.e8. [DOI: 10.1053/j.gastro.2015.12.038] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 12.3] [Reference Citation Analysis]
161 Shoreibah M, Anand BS, Singal AK. Alcoholic hepatitis and concomitant hepatitis C virus infection. World J Gastroenterol 2014; 20(34): 11929-11934 [PMID: 25232227 DOI: 10.3748/wjg.v20.i34.11929] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
162 Shen Y, Zhang J, Cai H, Shao JG, Zhang YY, Liu YM, Qin G, Qin Y. Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls. BMC Gastroenterol. 2015;15:32. [PMID: 25887997 DOI: 10.1186/s12876-015-0263-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
163 Chrostek L, Przekop D, Gruszewska E, Gudowska-Sawczuk M, Cylwik B. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics. Biomed Res Int 2019;2019:3646975. [PMID: 31192254 DOI: 10.1155/2019/3646975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Daswani R, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Role of liver transplantation in severe alcoholic hepatitis. Clin Mol Hepatol 2018;24:43-50. [PMID: 29316778 DOI: 10.3350/cmh.2017.0027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
165 Kounakis K, Chaniotakis M, Markaki M, Tavernarakis N. Emerging Roles of Lipophagy in Health and Disease. Front Cell Dev Biol. 2019;7:185. [PMID: 31552248 DOI: 10.3389/fcell.2019.00185] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
166 Xiao J, Zhang R, Huang F, Liu L, Deng Y, Ma Y, Wei Z, Tang X, Zhang Y, Zhang M. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Confers a Protective Activity against Alcoholic Liver Disease in Mice by Alleviating Mitochondrial Dysfunction. J Agric Food Chem 2017;65:5000-9. [PMID: 28562048 DOI: 10.1021/acs.jafc.7b01844] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
167 Dong Y, Qiu P, Zhao L, Zhang P, Huang X, Li C, Chai K, Shou D. Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis.Phytomedicine. 2020;74:152697. [PMID: 30392748 DOI: 10.1016/j.phymed.2018.09.232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
168 Wu W, Chen Y, Zhu B, Peng X, Zhang S, Zhou M. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice. Biochimie 2015;115:86-92. [DOI: 10.1016/j.biochi.2015.05.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
169 Stickel F, Datz C, Hampe J, Bataller R. Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017;11:173-188. [PMID: 28274107 DOI: 10.5009/gnl16477] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 18.0] [Reference Citation Analysis]
170 Prystupa A, Kiciński P, Luchowska-Kocot D, Błażewicz A, Niedziałek J, Mizerski G, Jojczuk M, Ochal A, Sak JJ, Załuska W. Association between Serum Selenium Concentrations and Levels of Proinflammatory and Profibrotic Cytokines-Interleukin-6 and Growth Differentiation Factor-15, in Patients with Alcoholic Liver Cirrhosis. Int J Environ Res Public Health 2017;14:E437. [PMID: 28430124 DOI: 10.3390/ijerph14040437] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
171 Brunt EM, Neuschwander-tetri BA, Burt AD. Fatty liver disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 293-359. [DOI: 10.1016/b978-0-7020-3398-8.00006-4] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
172 Yokoyama S, Hiramoto K, Koyama M, Ooi K. Chronic liver injury in mice promotes impairment of skin barrier function via tumor necrosis factor-alpha. Cutan Ocul Toxicol 2016;35:194-203. [PMID: 26362357 DOI: 10.3109/15569527.2015.1076433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
173 Summa KC, Voigt RM, Forsyth CB, Shaikh M, Cavanaugh K, Tang Y, Vitaterna MH, Song S, Turek FW, Keshavarzian A. Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation. PLoS One. 2013;8:e67102. [PMID: 23825629 DOI: 10.1371/journal.pone.0067102] [Cited by in Crossref: 134] [Cited by in F6Publishing: 129] [Article Influence: 14.9] [Reference Citation Analysis]
174 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 390] [Cited by in F6Publishing: 292] [Article Influence: 55.7] [Reference Citation Analysis]
175 Liu H, Liu M, Fu X, Zhang Z, Zhu L, Zheng X, Liu J. Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota. Nutrients 2018;10:E1298. [PMID: 30217037 DOI: 10.3390/nu10091298] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
176 Williams JA, Manley S, Ding WX. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol 2014; 20(36): 12908-12933 [PMID: 25278688 DOI: 10.3748/wjg.v20.i36.12908] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
177 Anestopoulos I, Voulgaridou GP, Georgakilas AG, Franco R, Pappa A, Panayiotidis MI. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacol Ther. 2015;145:103-119. [PMID: 25205159 DOI: 10.1016/j.pharmthera.2014.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
178 Guo R, Xu X, Babcock SA, Zhang Y, Ren J. Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy. J Hepatol. 2015;62:647-656. [PMID: 25457208 DOI: 10.1016/j.jhep.2014.10.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
179 Zhao H, Li H, Lai Q, Yang Q, Dong Y, Liu X, Wang W, Zhang J, Jia L. Antioxidant and hepatoprotective activities of modified polysaccharides from Coprinus comatus in mice with alcohol-induced liver injury. Int J Biol Macromol 2019;127:476-85. [PMID: 30659878 DOI: 10.1016/j.ijbiomac.2019.01.067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
180 Hamano M, Kamada Y, Kiso S, Furuta K, Kizu T, Chatani N, Egawa M, Takemura T, Ezaki H, Yoshida Y. Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction: Health check-up study of Japanese men. Hepatol Res. 2013;43:238-248. [PMID: 22835062 DOI: 10.1111/j.1872-034x.2012.01066.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
181 Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Farré M, Tor J, Muga R. Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence. J Addict Med 2017;11:34-9. [PMID: 27753720 DOI: 10.1097/ADM.0000000000000266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
182 Tada T, Toyoda H, Yasuda S, Miyake N, Kumada T, Kurisu A, Ohisa M, Akita T, Tanaka J. Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model. Eur J Gastroenterol Hepatol 2019;31:1452-9. [PMID: 31082998 DOI: 10.1097/MEG.0000000000001434] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Neuman MG, Maor Y, Nanau RM, Melzer E, Mell H, Opris M, Cohen L, Malnick S. Alcoholic Liver Disease: Role of Cytokines. Biomolecules 2015;5:2023-34. [PMID: 26343741 DOI: 10.3390/biom5032023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
184 Kim BH, Jung SH, Jung S. Beet root (Beta vulgaris) protects lipopolysaccharide and alcohol-induced liver damage in rat. Toxicol Res 2020;36:275-82. [PMID: 32685432 DOI: 10.1007/s43188-019-00030-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
185 Huang S, Li J, Shearer GC, Lichtenstein AH, Zheng X, Wu Y, Jin C, Wu S, Gao X. Longitudinal study of alcohol consumption and HDL concentrations: a community-based study. Am J Clin Nutr 2017;105:905-12. [PMID: 28251934 DOI: 10.3945/ajcn.116.144832] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
186 Shipley LC, Singal AK. Liver transplantation for alcoholic hepatitis. Transl Gastroenterol Hepatol 2020;5:26. [PMID: 32258530 DOI: 10.21037/tgh.2019.11.17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Winder GS, Fernandez AC, Klevering K, Mellinger JL. Confronting the Crisis of Comorbid Alcohol Use Disorder and Alcohol-Related Liver Disease With a Novel Multidisciplinary Clinic. Psychosomatics 2020;61:238-53. [PMID: 32033835 DOI: 10.1016/j.psym.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
188 Lucey MR. Liver transplantation for alcoholic cirrhosis in Japan. Liver Transpl 2014;20:255-6. [PMID: 24478042 DOI: 10.1002/lt.23834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
189 Junna L, Moustgaard H, Martikainen P. Unemployment from stable, downsized and closed workplaces and alcohol-related mortality. Addiction 2021;116:74-82. [PMID: 32364282 DOI: 10.1111/add.15106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Yang L, Yang C, Thomes PG, Kharbanda KK, Casey CA, McNiven MA, Donohue TM Jr. Lipophagy and Alcohol-Induced Fatty Liver. Front Pharmacol. 2019;10:495. [PMID: 31143122 DOI: 10.3389/fphar.2019.00495] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
191 Obed A, Bashir A, Stern S, Jarrad A. Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story. Clin Mol Hepatol 2018;24:358-66. [PMID: 30360030 DOI: 10.3350/cmh.2018.0044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
192 Neuman MG, Cohen L, Zakhari S, Nanau RM, Mueller S, Schneider M, Parry C, Isip R, Seitz HK. Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012. Alcohol Alcohol 2014;49:373-80. [PMID: 24816574 DOI: 10.1093/alcalc/agu021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
193 Berlakovich GA. Challenges in transplantation for alcoholic liver disease. World J Gastroenterol 2014; 20(25): 8033-8039 [PMID: 25009374 DOI: 10.3748/wjg.v20.i25.8033] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
194 Liu XY, Chen GN, DU GM, Pan Y, Song WQ, Jiang TW, Liu HL. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice. Chin J Nat Med 2020;18:186-95. [PMID: 32245588 DOI: 10.1016/S1875-5364(20)30020-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Srinivasan MP, Bhopale KK, Amer SM, Wan J, Kaphalia L, Ansari GS, Kaphalia BS. Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice. Biomolecules 2019;9:E560. [PMID: 31581705 DOI: 10.3390/biom9100560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
196 Lam P, Cheung F, Tan HY, Wang N, Yuen MF, Feng Y. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. Int J Mol Sci. 2016;17:465. [PMID: 27043533 DOI: 10.3390/ijms17040465] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
197 Su CW, Yang YY, Lin HC. Impact of etiological treatment on prognosis. Hepatol Int 2018;12:56-67. [PMID: 28702738 DOI: 10.1007/s12072-017-9807-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
198 Xiao J, Wu C, He Y, Guo M, Peng Z, Liu Y, Liu L, Dong L, Guo Z, Zhang R, Zhang M. Rice Bran Phenolic Extract Confers Protective Effects against Alcoholic Liver Disease in Mice by Alleviating Mitochondrial Dysfunction via the PGC-1α-TFAM Pathway Mediated by microRNA-494-3p. J Agric Food Chem 2020;68:12284-94. [PMID: 33094608 DOI: 10.1021/acs.jafc.0c04539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
199 Yang R, Guan MJ, Zhao N, Li MJ, Zeng T. Roles of extrahepatic lipolysis and the disturbance of hepatic fatty acid metabolism in TNF-α -induced hepatic steatosis. Toxicology 2019;411:172-80. [PMID: 30359672 DOI: 10.1016/j.tox.2018.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
200 Wang Y, Wang P, Xie J, Yin Z, Lin X, Zhao Y, Li Z, Chen T, Gu S, Lv Q, Zhao Z, Xu C. Pharmacokinetic Comparisons of Different Combinations of Yigan Jiangzhi Formula in Rats: Simultaneous Determination of Fourteen Components by UPLC-MS/MS. J Anal Methods Chem 2020;2020:9353975. [PMID: 32280556 DOI: 10.1155/2020/9353975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
201 Sood A, Khurana MS, Mahajan R, Midha V, Puri S, Kaur A, Gupta N, Sharma S. Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease: IgA anti-tTG in cirrhosis. Journal of Gastroenterology and Hepatology 2017;32:446-50. [DOI: 10.1111/jgh.13474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Choi Y, Abdelmegeed MA, Song BJ. Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver-adipose tissue axis. J Nutr Biochem 2018;55:12-25. [PMID: 29331880 DOI: 10.1016/j.jnutbio.2017.11.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
203 Lívero FA, Acco A. Molecular basis of alcoholic fatty liver disease: From incidence to treatment. Hepatol Res. 2016;46:111-123. [PMID: 26417962 DOI: 10.1111/hepr.12594] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
204 Radisavljevic MM, Bjelakovic GB, Nagorni AV, Stojanovic MP, Radojkovicn MD, Jovic JZ, Ignjatovic AM, Radisavljevic MM, Simonovic MM. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores? Med Princ Pract. 2017;26:169-175. [PMID: 27676412 DOI: 10.1159/000451057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
205 Bruch-Bertani JP, Uribe-Cruz C, Pasqualotto A, Longo L, Ayres R, Beskow CB, Barth AL, Lima-Morales D, Meurer F, Tayguara Silveira Guerreiro G, da Silveira TR, Álvares-da-Silva MR, Dall'Alba V. Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish. J Am Coll Nutr 2020;39:163-70. [PMID: 31241423 DOI: 10.1080/07315724.2019.1627955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
206 Sun Q, Zhang W, Zhong W, Sun X, Zhou Z. Dietary Fisetin Supplementation Protects Against Alcohol-Induced Liver Injury in Mice. Alcohol Clin Exp Res 2016;40:2076-84. [PMID: 27575873 DOI: 10.1111/acer.13172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
207 Kanak MA, Shindo Y, Saikumar P, Naziruddin B. Role of Inflammasomes in the Development of Gastrointestinal Diseases. In: Cordero MD, Alcocer-gómez E, editors. Inflammasomes: Clinical and Therapeutic Implications. Cham: Springer International Publishing; 2018. pp. 235-68. [DOI: 10.1007/978-3-319-89390-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
208 Im GY. Acute Alcoholic Hepatitis. Clin Liver Dis 2019;23:81-98. [PMID: 30454835 DOI: 10.1016/j.cld.2018.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
209 Kong X, Yang Y, Ren L, Shao T, Li F, Zhao C, Liu L, Zhang H, McClain CJ, Feng W. Activation of autophagy attenuates EtOH-LPS-induced hepatic steatosis and injury through MD2 associated TLR4 signaling. Sci Rep. 2017;7:9292. [PMID: 28839246 DOI: 10.1038/s41598-017-09045-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
210 Buzzetti E, Kalafateli M, Thorburn D, Davidson BR, Thiele M, Gluud LL, Del Giovane C, Askgaard G, Krag A, Tsochatzis E, Gurusamy KS. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. Cochrane Database Syst Rev 2017;3:CD011646. [PMID: 28368093 DOI: 10.1002/14651858.CD011646.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
211 Kim JW, Roh YS, Jeong H, Yi HK, Lee MH, Lim CW, Kim B. Spliceosome-Associated Protein 130 Exacerbates Alcohol-Induced Liver Injury by Inducing NLRP3 Inflammasome-Mediated IL-1β in Mice. Am J Pathol 2018;188:967-80. [PMID: 29355515 DOI: 10.1016/j.ajpath.2017.12.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
212 Diesinger T, Buko V, Lautwein A, Dvorsky R, Belonovskaya E, Lukivskaya O, Naruta E, Kirko S, Andreev V, Buckert D, Bergler S, Renz C, Schneider E, Kuchenbauer F, Kumar M, Günes C, Büchele B, Simmet T, Müller-Enoch D, Wirth T, Haehner T. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis. PLoS One 2020;15:e0235990. [PMID: 32701948 DOI: 10.1371/journal.pone.0235990] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
213 Romero F, Shah D, Duong M, Stafstrom W, Hoek JB, Kallen CB, Lang CH, Summer R. Chronic alcohol ingestion in rats alters lung metabolism, promotes lipid accumulation, and impairs alveolar macrophage functions. Am J Respir Cell Mol Biol 2014;51:840-9. [PMID: 24940828 DOI: 10.1165/rcmb.2014-0127OC] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
214 Tiniakos DG, Anstee QM, Burt AD. Fatty Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 308-71. [DOI: 10.1016/b978-0-7020-6697-9.00005-4] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
215 Latchoumycandane C, Nagy LE, McIntyre TM. Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption. Free Radic Biol Med 2015;86:179-90. [PMID: 26003521 DOI: 10.1016/j.freeradbiomed.2015.05.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
216 Wong GL, Espinosa WZ, Wong VW. Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Clin Mol Hepatol 2015;21:200-11. [PMID: 26523265 DOI: 10.3350/cmh.2015.21.3.200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
217 Wu YL, Huang SH, He CM, Qiu B, Liu JJ, Li J, Lin Y, Yu SL, Wang HF, Zhang GF. Dendrobium officinale Flower Extraction Mitigates Alcohol-Induced Liver Injury in Mice: Role of Antisteatosis, Antioxidative, and Anti-Inflammatory. Evid Based Complement Alternat Med 2020;2020:1421853. [PMID: 33149748 DOI: 10.1155/2020/1421853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Chou HW, Lin MH, Chen YS, Yu HY. Impact of MELD score and cardiopulmonary bypass duration on post-operative hypoxic hepatitis in patients with liver cirrhosis undergoing open heart surgery. J Formos Med Assoc 2020;119:838-44. [PMID: 31530414 DOI: 10.1016/j.jfma.2019.08.028] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
219 Ikejima K, Kon K, Yamashina S. Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights. Clin Mol Hepatol 2020;26:728-35. [PMID: 33053942 DOI: 10.3350/cmh.2020.0202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
220 Lakshman R, Shah R, Reyes-gordillo K, Varatharajalu R. Synergy between NAFLD and AFLD and potential biomarkers. Clinics and Research in Hepatology and Gastroenterology 2015;39:S29-34. [DOI: 10.1016/j.clinre.2015.05.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
221 Lu C, Zhang F, Xu W, Wu X, Lian N, Jin H, Chen Q, Chen L, Shao J, Wu L, Lu Y, Zheng S. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes: Curcumin Attenuates Ethanol-Induced Hepatic Steatosis. IUBMB Life 2015;67:645-58. [DOI: 10.1002/iub.1409] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
222 Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12:387-400. [PMID: 26055245 DOI: 10.1038/nrgastro.2015.94] [Cited by in Crossref: 270] [Cited by in F6Publishing: 262] [Article Influence: 38.6] [Reference Citation Analysis]
223 Wang R, Mu J. Arbutin attenuates ethanol-induced acute hepatic injury by the modulation of oxidative stress and Nrf-2/HO-1 signaling pathway. J Biochem Mol Toxicol 2021;:e22872. [PMID: 34346143 DOI: 10.1002/jbt.22872] [Reference Citation Analysis]
224 Lackner C, Spindelboeck W, Haybaeck J, Douschan P, Rainer F, Terracciano L, Haas J, Berghold A, Bataller R, Stauber RE. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol. 2017;66:610-618. [PMID: 27894795 DOI: 10.1016/j.jhep.2016.11.011] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 13.8] [Reference Citation Analysis]
225 Schneider ACR, Gregório C, Uribe-Cruz C, Guizzo R, Malysz T, Faccioni-Heuser MC, Longo L, da Silveira TR. Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver. World J Hepatol 2017; 9(8): 418-426 [PMID: 28357029 DOI: 10.4254/wjh.v9.i8.418] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
226 Gan Y, Chen X, Yi R, Zhao X. Antioxidative and Anti-Inflammatory Effects of Lactobacillus plantarum ZS62 on Alcohol-Induced Subacute Hepatic Damage. Oxid Med Cell Longev 2021;2021:7337988. [PMID: 34912498 DOI: 10.1155/2021/7337988] [Reference Citation Analysis]
227 Tian F, Chi F, Wang G, Liu X, Zhang Q, Chen Y, Zhang H, Chen W. Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. J Microbiol 2015;53:856-63. [DOI: 10.1007/s12275-015-5239-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
228 Wang HJ, Gao B, Zakhari S, Nagy LE. Inflammation in alcoholic liver disease. Annu Rev Nutr. 2012;32:343-368. [PMID: 22524187 DOI: 10.1146/annurev-nutr-072610-145138] [Cited by in Crossref: 174] [Cited by in F6Publishing: 166] [Article Influence: 17.4] [Reference Citation Analysis]
229 Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y, Iracheta-Vellve A, Adejumo A, Saha B, Calenda C, Mehta J, Lefebvre E, Vig P, Szabo G. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice. Hepatology. 2019;69:1105-1121. [PMID: 30179264 DOI: 10.1002/hep.30249] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
230 Ramos-tovar E, Muriel P. Does Nutrition Matter in Liver Disease? Liver Pathophysiology. Elsevier; 2017. pp. 743-59. [DOI: 10.1016/b978-0-12-804274-8.00053-9] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
231 De Ternay J, Naassila M, Nourredine M, Louvet A, Bailly F, Sescousse G, Maurage P, Cottencin O, Carrieri PM, Rolland B. Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain. Front Pharmacol 2019;10:627. [PMID: 31214036 DOI: 10.3389/fphar.2019.00627] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
232 Zeng T, Guo FF, Zhang CL, Song FY, Zhao XL, Xie KQ. Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis. PLoS One 2013;8:e54188. [PMID: 23335995 DOI: 10.1371/journal.pone.0054188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
233 Guo FF, Xiao M, Wang SY, Zeng T, Cheng L, Xie Q. Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods 2020;30:407-16. [PMID: 32237978 DOI: 10.1080/15376516.2020.1747126] [Reference Citation Analysis]
234 Bhattacharyya M, Barman NN, Goswami B. Survey of alcohol-related cirrhosis at a tertiary care center in North East India. Indian J Gastroenterol 2016;35:167-72. [DOI: 10.1007/s12664-016-0651-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
235 Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-1165. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 429] [Cited by in F6Publishing: 322] [Article Influence: 53.6] [Reference Citation Analysis]
236 Zeng T, Zhang CL, Song FY, Zhao XL, Xie KQ. CMZ reversed chronic ethanol-induced disturbance of PPAR-α possibly by suppressing oxidative stress and PGC-1α acetylation, and activating the MAPK and GSK3β pathway. PLoS One 2014;9:e98658. [PMID: 24892905 DOI: 10.1371/journal.pone.0098658] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
237 Nallagangula KS, Lakshmaiah V, Muninarayana C, Deepa KV, Shashidhar KN. A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis. J Circ Biomark 2018;7:1849454418788417. [PMID: 30034555 DOI: 10.1177/1849454418788417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
238 Parker R, Kim SJ, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat Rev Gastroenterol Hepatol. 2018;15:50-59. [PMID: 28930290 DOI: 10.1038/nrgastro.2017.116] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 11.6] [Reference Citation Analysis]
239 Cao HX, Fan JG. Editorial: Fatty liver disease: a growing public health problem worldwide. J Dig Dis. 2011;12:1-2. [PMID: 21091929 DOI: 10.1111/j.1751-2980.2010.00467.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
240 Hall MG, Grummon AH, Lazard AJ, Maynard OM, Taillie LS. Reactions to graphic and text health warnings for cigarettes, sugar-sweetened beverages, and alcohol: An online randomized experiment of US adults. Prev Med 2020;137:106120. [PMID: 32437703 DOI: 10.1016/j.ypmed.2020.106120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
241 Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol. 2011;4:63-81. [PMID: 21317995 DOI: 10.1177/1756283x10378925] [Cited by in Crossref: 84] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
242 Xie M, Tang H, Li F, Wu S, Dong Y, Yang Y, Baker JS, Ma J. Mediating Roles of hsCRP, TNF-α and Adiponectin on the Associations between Body Fat and Fatty Liver Disease among Overweight and Obese Adults. Biology (Basel) 2021;10:895. [PMID: 34571772 DOI: 10.3390/biology10090895] [Reference Citation Analysis]
243 Huang YS, Wang LY, Chang CH, Perng CL, Lin HC. Superoxide Dismutase 2 Genetic Variation as a Susceptibility Risk Factor for Alcoholic Cirrhosis. Alcohol Alcohol 2016;51:633-7. [PMID: 26873981 DOI: 10.1093/alcalc/agw004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
244 Cui Y, Jiang L, Shao Y, Mei L, Tao Y. Anti-alcohol liver disease effect of Gentianae macrophyllae extract through MAPK/JNK/p38 pathway. J Pharm Pharmacol 2019;71:240-50. [PMID: 30298517 DOI: 10.1111/jphp.13027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
245 Gallegos-Orozco JF, Charlton MR. Alcoholic Liver Disease and Liver Transplantation. Clin Liver Dis. 2016;20:521-534. [PMID: 27373614 DOI: 10.1016/j.cld.2016.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
246 Wan YM, Wu HM, Li YH, Xu ZY, Yang JH, Liu C, He YF, Wang MJ, Wu XN, Zhang Y. TSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis via Suppression of STAT3 Activation. Front Pharmacol 2020;11:10. [PMID: 32116692 DOI: 10.3389/fphar.2020.00010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
247 Jia Y, Jiang J, Zhao K, Zhang T, Sun P, Peng J, Yang Q, Qian Y. Disulfiram suppressed ethanol promoted RANKL-induced osteoclastogenesis in vitro and ethanol-induced osteoporosis in vivo via ALDH1A1-NFATc1 axis. Aging (Albany NY) 2019;11:8103-19. [PMID: 31596733 DOI: 10.18632/aging.102279] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
248 Machado MV, Cortez-Pinto H. Proangiogenic factors in the development of HCC in alcoholic cirrhosis. Clin Res Hepatol Gastroenterol 2015;39 Suppl 1:S104-8. [PMID: 26193870 DOI: 10.1016/j.clinre.2015.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
249 Singal AK, Chaha KS, Rasheed K, Anand BS. Liver transplantation in alcoholic liver disease current status and controversies. World J Gastroenterol 2013; 19(36): 5953-5963 [PMID: 24106395 DOI: 10.3748/wjg.v19.i36.5953] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
250 Childers RE, Ahn J. Diagnosis of Alcoholic Liver Disease: Key Foundations and New Developments. Clin Liver Dis 2016;20:457-71. [PMID: 27373609 DOI: 10.1016/j.cld.2016.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
251 Ma X, Luo Q, Zhu H, Liu X, Dong Z, Zhang K, Zou Y, Wu J, Ge J, Sun A. Aldehyde dehydrogenase 2 activation ameliorates CCl4 -induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway. J Cell Mol Med 2018. [PMID: 29799157 DOI: 10.1111/jcmm.13677] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
252 Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci. 2011;56:545-554. [PMID: 21127976 DOI: 10.1007/s10620-010-1501-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
253 Rehm J, Shield KD. Global Burden of Alcohol Use Disorders and Alcohol Liver Disease. Biomedicines 2019;7:E99. [PMID: 31847084 DOI: 10.3390/biomedicines7040099] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
254 Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, Long MT. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. Clin Gastroenterol Hepatol 2019; 17: 1157-1164. e4. [PMID: 30476583 DOI: 10.1016/j.cgh.2018.11.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
255 Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21(41): 11552-11566 [PMID: 26556986 DOI: 10.3748/wjg.v21.i41.11552] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
256 Lin CJ, Chiu CC, Chen YC, Chen ML, Hsu TC, Tzang BS. Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling. J Med Food 2015;18:1291-8. [PMID: 26090712 DOI: 10.1089/jmf.2014.3408] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
257 Pavlov CS, Casazza G, Nikolova D, Tsochatzis E, Burroughs AK, Ivashkin VT, Gluud C. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev 2015;1:CD010542. [PMID: 25612182 DOI: 10.1002/14651858.CD010542.pub2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
258 Hlaing NKT, Mitrani RA, Aung ST, Phyo WW, Serper M, Kyaw AMM, Bwa AH, Win KM, Reddy KR. Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience. J Viral Hepat 2017;24:927-35. [PMID: 28475232 DOI: 10.1111/jvh.12721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
259 Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology. 2012;55:1398-1405. [PMID: 22213344 DOI: 10.1002/hep.25544] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 10.5] [Reference Citation Analysis]
260 Zhao Y, Yang R, Xiao M, Guan M, Zhao N, Zeng T. Kupffer cells activation promoted binge drinking-induced fatty liver by activating lipolysis in white adipose tissues. Toxicology 2017;390:53-60. [DOI: 10.1016/j.tox.2017.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
261 Yan J, Nie Y, Luo M, Chen Z, He B. Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Front Pharmacol 2021;12:694475. [PMID: 34290612 DOI: 10.3389/fphar.2021.694475] [Reference Citation Analysis]
262 Kema VH, Khan I, Kapur S, Mandal P. Evaluating the effect of diallyl sulfide on regulation of inflammatory mRNA expression in 3T3L1 adipocytes and RAW 264.7 macrophages during ethanol treatment. Drug Chem Toxicol 2018;41:302-13. [PMID: 29319385 DOI: 10.1080/01480545.2017.1405969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
263 Wu J, Meng QH. Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease. World J Gastroenterol 2020; 26(31): 4567-4578 [PMID: 32884217 DOI: 10.3748/wjg.v26.i31.4567] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
264 Caruso MG, Veronese N, Notarnicola M, Cisternino AM, Reddavide R, Inguaggiato R, Guerra V, Donghia R, Logroscino A, Rotolo O, Chiloiro M, Leandro G, De Leonardis G, Tutino V, Misciagna G, Bonfiglio C, Guerra R, Osella A. Fatty liver and mortality: a cohort population study in South Italy. BMJ Open 2019;9:e027379. [PMID: 31227533 DOI: 10.1136/bmjopen-2018-027379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
265 Silva J, Spatz MH, Folk C, Chang A, Cadenas E, Liang J, Davies DL. Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK/Sirt-1/PGC-1α signaling axis. Alcohol 2021;91:1-9. [PMID: 33080338 DOI: 10.1016/j.alcohol.2020.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
266 Xia Y, Yang J, Sanyal AJ, Shah VH, Chalasani NP, Yu Q, Zheng X, Li W. Persistent Hyperactivation of Endothelial Cells in Patients with Alcoholic Hepatitis. Alcohol Clin Exp Res 2020;44:1075-87. [PMID: 32246771 DOI: 10.1111/acer.14331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
267 Kabarriti R, Guha C. Hedgehog signaling and radiation induced liver injury: a delicate balance. Hepatol Int 2014;8:316-20. [PMID: 26202634 DOI: 10.1007/s12072-014-9532-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
268 Hu CQ, Bo QL, Chu LL, Hu YD, Fu L, Wang GX, Lu Y, Liu XJ, Wang H, Xu DX. Vitamin D Deficiency Aggravates Hepatic Oxidative Stress and Inflammation during Chronic Alcohol-Induced Liver Injury in Mice. Oxid Med Cell Longev 2020;2020:5715893. [PMID: 32184917 DOI: 10.1155/2020/5715893] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
269 Dugum M, McCullough A. Diagnosis and Management of Alcoholic Liver Disease. J Clin Transl Hepatol 2015;3:109-16. [PMID: 26356792 DOI: 10.14218/JCTH.2015.00008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
270 Ma Y, Chai H, Ding Q, Qian Q, Yan Z, Ding B, Dou X, Li S. Hepatic SIRT3 Upregulation in Response to Chronic Alcohol Consumption Contributes to Alcoholic Liver Disease in Mice. Front Physiol 2019;10:1042. [PMID: 31474877 DOI: 10.3389/fphys.2019.01042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
271 Im GY, Kim-Schluger L, Shenoy A, Schubert E, Goel A, Friedman SL, Florman S, Schiano TD. Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States--A Single-Center Experience. Am J Transplant. 2016;16:841-849. [PMID: 26710309 DOI: 10.1111/ajt.13586] [Cited by in Crossref: 130] [Cited by in F6Publishing: 103] [Article Influence: 18.6] [Reference Citation Analysis]
272 Lafferty H, Stanley AJ, Forrest EH. The management of alcoholic hepatitis: a prospective comparison of scoring systems. Aliment Pharmacol Ther. 2013;38:603-610. [PMID: 23879668 DOI: 10.1111/apt.12414] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
273 Kraglund F, Deleuran T, Askgaard G, Fleming KM, Jepsen P. Decreasing Incidence of Alcohol-Related Liver Disease in Denmark: A 25-Year Nationwide Study. Clin Epidemiol 2021;13:1-11. [PMID: 33442297 DOI: 10.2147/CLEP.S287870] [Reference Citation Analysis]
274 Magdaleno F, Blajszczak CC, Nieto N. Key Events Participating in the Pathogenesis of  Alcoholic Liver Disease. Biomolecules 2017;7:E9. [PMID: 28134813 DOI: 10.3390/biom7010009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
275 Dou X, Xia Y, Chen J, Qian Y, Li S, Zhang X, Song Z. Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease. Br J Pharmacol. 2014;171:4073-4086. [PMID: 24819676 DOI: 10.1111/bph.12765] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
276 Montejo González JC, Mesejo A, Bonet Saris A; Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): liver failure and transplantation]. Med Intensiva 2011;35 Suppl 1:28-32. [PMID: 22309749 DOI: 10.1016/S0210-5691(11)70006-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
277 Strassburg CP. [Patient selection and indications for liver transplantation]. Chirurg. 2013;84:363-371. [PMID: 23576124 DOI: 10.1007/s00104-012-2418-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
278 Gala KS, Vatsalya V. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope. Cells 2020;9:E524. [PMID: 32106390 DOI: 10.3390/cells9030524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
279 Lucey MR, Im GY, Mellinger JL, Szabo G, Crabb DW. Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease. Liver Transpl 2020;26:14-6. [PMID: 31299131 DOI: 10.1002/lt.25600] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
280 Clapcote SJ. Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases. In: Zhang H, Xu Y, O'donnell JM, editors. Phosphodiesterases: CNS Functions and Diseases. Cham: Springer International Publishing; 2017. pp. 103-31. [DOI: 10.1007/978-3-319-58811-7_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
281 Yang K, Huang Y, Perng C, Lin H, Lee S. Polymorphism of N-acetyltransferase 2 Gene and the Susceptibility to Alcoholic Liver Cirrhosis: Interaction With Smoking: NAT2 GENE AND ALCOHOLIC LIVER CIRRHOSIS. Alcoholism: Clinical and Experimental Research 2011;35:1204-8. [DOI: 10.1111/j.1530-0277.2011.01453.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
282 Stice CP, Xia H, Wang XD. Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development. Chronic Dis Transl Med 2018;4:211-24. [PMID: 30603740 DOI: 10.1016/j.cdtm.2018.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
283 Phukan JP, Sinha A, Deka JP. Serum lipid profile in alcoholic cirrhosis: A study in a teaching hospital of north-eastern India. Niger Med J 2013;54:5-9. [PMID: 23661892 DOI: 10.4103/0300-1652.108886] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
284 Gonçalves PL, Zago-Gomes Mda P, Marques CC, Mendonça AT, Gonçalves CS, Pereira FE. Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espírito Santo. Clinics (Sao Paulo) 2013;68:291-5. [PMID: 23644846 DOI: 10.6061/clinics/2013(03)oa02] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
285 Neuman MG, Malnick S, Maor Y, Nanau RM, Melzer E, Ferenci P, Seitz HK, Mueller S, Mell H, Samuel D, Cohen LB, Kharbanda KK, Osna NA, Ganesan M, Thompson KJ, Mckillop IH, Bautista A, Bataller R, French SW. Alcoholic liver disease: Clinical and translational research. Experimental and Molecular Pathology 2015;99:596-610. [DOI: 10.1016/j.yexmp.2015.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
286 Darwish HA, Abd Raboh NR, Mahdy A. Camel's milk alleviates alcohol-induced liver injury in rats. Food Chem Toxicol 2012;50:1377-83. [PMID: 22281157 DOI: 10.1016/j.fct.2012.01.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
287 Shin MK, Yang SM, Han IS. Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. Anim Cells Syst (Seoul) 2020;24:214-9. [PMID: 33029298 DOI: 10.1080/19768354.2020.1810771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
288 Barritt AS, Jiang Y, Schmidt M, Hayashi PH, Bataller R. Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis. Dig Dis Sci 2019;64:1460-9. [DOI: 10.1007/s10620-019-5471-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
289 Hilscher M, Shah V. Alcoholic Liver Disease. In: Wallace MB, Aqel BA, Lindor KD, Talley NJ, Devault KR, editors. Practical Gastroenterology and Hepatology Board Review Toolkit. Oxford: John Wiley & Sons, Ltd; 2016. pp. 498-502. [DOI: 10.1002/9781119127437.ch79] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
290 Doggui R, Elsawy W, Conti AA, Baldacchino A. Association between chronic psychoactive substances use and systemic inflammation: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021;125:208-20. [PMID: 33639179 DOI: 10.1016/j.neubiorev.2021.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
291 Seo W, Jeong WI. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease? World J Gastroenterol 2016; 22(4): 1348-1356 [PMID: 26819504 DOI: 10.3748/wjg.v22.i4.1348] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
292 Yan R, Chu J, Zhou Y, Shan W, Hu Y, Lin M, Zhao Y, Sun R, Wang Z, Lv L, Wang L, Yao J, Zhang N. Ubiquitin-specific protease 22 ameliorates chronic alcohol-associated liver disease by regulating BRD4. Pharmacol Res 2021;168:105594. [PMID: 33826947 DOI: 10.1016/j.phrs.2021.105594] [Reference Citation Analysis]
293 Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C. Glucocorticosteroids for people with alcoholic hepatitis. Cochrane Database Syst Rev 2019;4:CD001511. [PMID: 30964545 DOI: 10.1002/14651858.CD001511.pub4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
294 Karsan HA, Parekh S. Management of alcoholic hepatitis: Current concepts. World J Hepatol 2012; 4(12): 335-341 [PMID: 23355911 DOI: 10.4254/wjh.v4.i12.335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
295 Pavlov CS, Casazza G, Pavlova M, Nikolova D, Tsochatzis E, Liusina E, Gluud C, Pavlov CS. Ultrasonography for diagnosis of cirrhosis in people with alcoholic liver disease. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd011602] [Cited by in Crossref: 8] [Article Influence: 1.1] [Reference Citation Analysis]
296 Shetty S, Venkatakrishnan L, Krishanveni J, Kumari S. Transjugular liver biopsy in severe alcoholic hepatitis. Indian J Gastroenterol 2017;36:23-6. [DOI: 10.1007/s12664-016-0720-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
297 Ye S, Boeter JW, Mihajlovic M, Steenbeek FG, Wolferen ME, Oosterhoff LA, Marsee A, Caiazzo M, Laan LJ, Penning LC, Vermonden T, Spee B, Schneeberger K. A Chemically Defined Hydrogel for Human Liver Organoid Culture. Adv Funct Mater 2020;30:2000893. [DOI: 10.1002/adfm.202000893] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
298 Lee SB, Kim KM, An J, Lee D, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int. 2016;36:1351-1361. [PMID: 26913702 DOI: 10.1111/liv.13099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
299 Ambade A, Satishchandran A, Szabo G. Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation. Sci Rep 2016;6:21340. [PMID: 26888602 DOI: 10.1038/srep21340] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
300 Wernlund PG, Støy S, Lemming L, Vilstrup H, Sandahl TD. Blood culture-positive infections in patients with alcoholic hepatitis. Scandinavian Journal of Infectious Diseases 2014;46:902-5. [DOI: 10.3109/00365548.2014.951682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
301 Ahmed Mohammed HA, Yang JD, Giama NH, Choi J, Ali HM, Mara KC, Harmsen WS, Wiesner RH, Leise MD, Therneau TM, Roberts LR. Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis. Liver Cancer. 2017;6:126-136. [PMID: 28275579 DOI: 10.1159/000450833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
302 Ma M, Falloon K, Chen PH, Saberi B, Pustavoitau A, Ozdogan E, Li Z, Philosophe B, Cameron AM, Gurakar A. The Role of Liver Transplantation in Alcoholic Hepatitis. J Intensive Care Med 2019;34:277-91. [PMID: 29879862 DOI: 10.1177/0885066618780339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Yang Y, Ai G, Wang M. Alcoholic liver disease and intestinal microecology. Shijie Huaren Xiaohua Zazhi 2019; 27(1): 43-49 [DOI: 10.11569/wcjd.v27.i1.43] [Reference Citation Analysis]
304 Tong M, Longato L, Ramirez T, Zabala V, Wands JR, de la Monte SM. Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin. Int J Exp Pathol. 2014;95:49-63. [PMID: 24456332 DOI: 10.1111/iep.12052] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
305 Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 2012;27 Suppl 2:89-93. [PMID: 22320924 DOI: 10.1111/j.1440-1746.2011.07003.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 110] [Article Influence: 11.7] [Reference Citation Analysis]
306 Piano S, Marchioro L, Gola E, Rosi S, Morando F, Cavallin M, Sticca A, Fasolato S, Forza G, Chiara Frigo A. Assessment of alcohol consumption in liver transplant candidates and recipients: the best combination of the tools available. Liver Transpl. 2014;20:815-822. [PMID: 24692331 DOI: 10.1002/lt.23881] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
307 Mellinger JL, Scott Winder G, DeJonckheere M, Fontana RJ, Volk ML, Lok ASF, Blow FC. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis. J Subst Abuse Treat 2018;91:20-7. [PMID: 29910011 DOI: 10.1016/j.jsat.2018.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
308 Garcia-Saenz-de-Sicilia M, Duvoor C, Altamirano J, Chavez-Araujo R, Prado V, de Lourdes Candolo-Martinelli A, Holanda-Almeida P, Becerra-Martins-de-Oliveira B, Fernandez-de-Almeida S, Bataller R, Caballeria J, Duarte-Rojo A. A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis. Am J Gastroenterol 2017;112:306-15. [PMID: 27922027 DOI: 10.1038/ajg.2016.539] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
309 Tang X, Wei R, Deng A, Lei T. Protective Effects of Ethanolic Extracts from Artichoke, an Edible Herbal Medicine, against Acute Alcohol-Induced Liver Injury in Mice. Nutrients 2017;9:E1000. [PMID: 28891983 DOI: 10.3390/nu9091000] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
310 Grillet F, Calame P, Cervoni JP, Weil D, Thevenot T, Ronot M, Delabrousse E. Non-invasive diagnosis of severe alcoholic hepatitis: Usefulness of cross-sectional imaging. Diagn Interv Imaging 2021;102:247-54. [PMID: 33069642 DOI: 10.1016/j.diii.2020.09.009] [Reference Citation Analysis]
311 Shalimar, Kedia S, Mahapatra SJ, Nayak B, Gunjan D, Thakur B, Acharya SK. Severity and Outcome of Acute-on-Chronic Liver Failure is Dependent on the Etiology of Acute Hepatic Insults: Analysis of 368 Patients. Journal of Clinical Gastroenterology 2017;51:734-41. [DOI: 10.1097/mcg.0000000000000823] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
312 Veronese N, Notarnicola M, Cisternino AM, Reddavide R, Inguaggiato R, Guerra V, Rotolo O, Zinzi I, Leandro G, Correale M, Tutino V, Misciagna G, Osella AR, Bonfiglio C, Giannelli G, Caruso MG; MICOL Group. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area. Nutrients 2018;10:E89. [PMID: 29342916 DOI: 10.3390/nu10010089] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
313 Noh BK, Lee JK, Jun HJ, Lee JH, Jia Y, Hoang MH, Kim JW, Park KH, Lee SJ. Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase. Biochem Biophys Res Commun. 2011;414:361-366. [PMID: 21964292 DOI: 10.1016/j.bbrc.2011.09.077] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
314 Li Z, Lian Y, Wei R, Jin L, Cao H, Zhao T, Ma X, Zhong M, Gao Y, Zhang K. Effects of taraxasterol against ethanol and high-fat diet-induced liver injury by regulating TLR4/MyD88/NF-κB and Nrf2/HO-1 signaling pathways. Life Sci 2020;262:118546. [PMID: 33035580 DOI: 10.1016/j.lfs.2020.118546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
315 Vilarrasa E, Puig L. Psoriasis: Biologic treatment and liver disease. World J Dermatol 2014; 3(4): 76-85 [DOI: 10.5314/wjd.v3.i4.76] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
316 Saberi B, Dadabhai AS, Jang YY, Gurakar A, Mezey E. Current Management of Alcoholic Hepatitis and Future Therapies. J Clin Transl Hepatol 2016;4:113-22. [PMID: 27350941 DOI: 10.14218/JCTH.2016.00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
317 Jimborean MA, Salanță LC, Trusek A, Pop CR, Tofană M, Mudura E, Coldea TE, Farcaș A, Ilieș M, Pașca S, Uifălean A. Drinking Behavior, Taste Preferences and Special Beer Perception among Romanian University Students: A Qualitative Assessment Research. Int J Environ Res Public Health 2021;18:3307. [PMID: 33806851 DOI: 10.3390/ijerph18063307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Huang A, Chang B, Sun Y, Lin H, Li B, Teng G, Zou ZS. Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013: A large tertiary referral hospital experience from 7422 patients. Medicine (Baltimore) 2017;96:e6163. [PMID: 28207552 DOI: 10.1097/MD.0000000000006163] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
319 Tyson CC, Nwankwo C, Lin PH, Svetkey LP. The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. Curr Hypertens Rep. 2012;14:388-396. [PMID: 22846984 DOI: 10.1007/s11906-012-0296-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
320 Chen Y, Jin X, Xiang Z, Chen S, Li Y. Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis. Liver Int 2013;33:1257-65. [DOI: 10.1111/liv.12196] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
321 Kröner PT, Mankal PK, Dalapathi V, Shroff K, Abed J, Kotler DP. Alcohol-Attributable Fraction in Liver Disease: Does GDP Per Capita Matter? Ann Glob Health 2015;81:711-7. [PMID: 27036730 DOI: 10.1016/j.aogh.2015.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
322 Parker R, McCune CA. Diagnosis and treatment of alcoholic hepatitis. Frontline Gastroenterol 2014;5:123-9. [PMID: 28839759 DOI: 10.1136/flgastro-2013-100373] [Reference Citation Analysis]
323 Iracheta-Vellve A, Petrasek J, Satishchandran A, Gyongyosi B, Saha B, Kodys K, Fitzgerald KA, Kurt-Jones EA, Szabo G. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice. J Hepatol 2015;63:1147-55. [PMID: 26100496 DOI: 10.1016/j.jhep.2015.06.013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 10.1] [Reference Citation Analysis]
324 Qi N, Liu C, Yang H, Shi W, Wang S, Zhou Y, Wei C, Gu F, Qin Y. Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress. Oncotarget 2017;8:88079-93. [PMID: 29152143 DOI: 10.18632/oncotarget.21404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
325 Chen L, Zhang Q, Yu C, Wang F, Kong X. Functional roles of CCL5/RANTES in liver disease. Liver Research 2020;4:28-34. [DOI: 10.1016/j.livres.2020.01.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
326 Shearn CT, Smathers RL, Jiang H, Orlicky DJ, Maclean KN, Petersen DR. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis. J Nutr Biochem 2013;24:1436-45. [PMID: 23465594 DOI: 10.1016/j.jnutbio.2012.12.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
327 Huo X, Sun X, Cao Z, Qiao J, Yang S, Meng X, Zhao Y. Optimal ratio of 18α- and 18β-glycyrrhizic acid for preventing alcoholic hepatitis in rats. Exp Ther Med 2019;18:172-8. [PMID: 31258651 DOI: 10.3892/etm.2019.7572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
328 Kim YD, Lee KM, Hwang S, Chang HW, Kim K, Harris RA, Choi H, Choi W, Lee S, Park C. Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015;1852:2662-70. [DOI: 10.1016/j.bbadis.2015.09.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
329 Li TH, Yang YY, Huang CC, Liu CW, Tsai HC, Lin MW, Tsai CY, Huang SF, Wang YW, Lee TY, Huang YH, Hou MC, Lin HC. Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis. Clin Sci (Lond) 2019;133:531-44. [PMID: 30602573 DOI: 10.1042/CS20180873] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
330 Dunne PDJ, Forrest EH. Review article: recent insights into clinical decision-making in severe alcoholic hepatitis. Aliment Pharmacol Ther 2017;46:274-81. [PMID: 28543549 DOI: 10.1111/apt.14144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
331 Verma M, Chu JN, Salama JAF, Faiz MT, Eweje F, Gwynne D, Lopes A, Hess K, Soares V, Steiger C, McManus R, Koeppen R, Hua T, Hayward A, Collins J, Tamang SM, Ishida K, Miller JB, Katz S, Slocum AH, Sulkowski MS, Thomas DL, Langer R, Traverso G. Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine. Proc Natl Acad Sci U S A 2020;117:11987-94. [PMID: 32424082 DOI: 10.1073/pnas.2004746117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
332 Liu J, Lv XW, Zhang L, Wang H, Li J, Wu B. Review on Biological Characteristics of Kv1.3 and Its Role in Liver Diseases. Front Pharmacol 2021;12:652508. [PMID: 34093186 DOI: 10.3389/fphar.2021.652508] [Reference Citation Analysis]
333 Kim TH, Um SH, Yim SY, Seo YS, Yim HJ, Jeen YT, Lee HS, Chun HJ, Kim CD, Ahn H, Lee Y. The risk of perioperative adverse events in patients with chronic liver disease. Liver Int. 2015;35:713-723. [PMID: 24620863 DOI: 10.1111/liv.12529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
334 Liu T, Yao M, Liu S, Wang L, Wang L, Hou J, Ma X, Jia J, Zhao J, Zhuang H, Lu F. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma. Oncotarget. 2017;8:16498-16506. [PMID: 28157705 DOI: 10.18632/oncotarget.14954] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
335 Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol. 2010;7:250-254. [PMID: 20305686 DOI: 10.1038/cmi.2010.5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
336 Spahr L, Rubbia-Brandt L, Genevay M, Hadengue A, Giostra E. Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterol. 2011;11:115. [PMID: 22035247 DOI: 10.1186/1471-230x-11-115] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
337 Koc ÖM, Robaeys G, Yildirim B, Posthouwer D, Hens N, Koek GH. The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection. J Med Virol 2019;91:623-9. [PMID: 30381836 DOI: 10.1002/jmv.25353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
338 Kwon OS, Jung YK, Kim YS, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS, Chun BC, Kim JH. Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study. Korean J Hepatol. 2010;16:308-314. [PMID: 20924214 DOI: 10.3350/kjhep.2010.16.3.308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
339 Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011;35:787-793. [PMID: 21284667 DOI: 10.1111/j.1530-0277.2010.01399.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 112] [Article Influence: 9.5] [Reference Citation Analysis]
340 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
341 Mellinger JL. Epidemiology of Alcohol Use and Alcoholic Liver Disease.Clin Liver Dis (Hoboken). 2019;13:136-139. [PMID: 31236261 DOI: 10.1002/cld.806] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
342 Forsyth CB, Voigt RM, Keshavarzian A. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness. Redox Biol 2014;3:40-6. [PMID: 25462064 DOI: 10.1016/j.redox.2014.10.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
343 Arsene D, Farooq O, Bataller R. New therapeutic targets in alcoholic hepatitis. Hepatol Int 2016;10:538-52. [PMID: 27072540 DOI: 10.1007/s12072-015-9701-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
344 Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol 2014; 20(44): 16443-16451 [PMID: 25469012 DOI: 10.3748/wjg.v20.i44.16443] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
345 Knorr J, Wree A, Tacke F, Feldstein AE. The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. Semin Liver Dis 2020;40:298-306. [PMID: 32526788 DOI: 10.1055/s-0040-1708540] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
346 Magri MC, Nunes AKDS, Dantas BP, Manchiero C, Prata TVG, Alves GM, Tengan FM. Meta-Analysis of the Prevalence of HBV Infection Among Alcohol Users Worldwide. Alcohol Alcohol 2020;55:136-43. [PMID: 31912149 DOI: 10.1093/alcalc/agz102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 Qin G, Shao JG, Zhu YC, Xu AD, Yao JH, Wang XL, Qian YK, Wang HY, Shen Y, Lu P, Wang LJ. Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study. J Clin Gastroenterol. 2016;50:670-675. [PMID: 27136963 DOI: 10.1097/mcg.0000000000000538] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
348 Parker R, Armstrong MJ, Corbett C, Rowe IA, Houlihan DD. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther 2013;37:845-54. [PMID: 23489011 DOI: 10.1111/apt.12279] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
349 Szabo G, Petrasek J. Gut-liver axis and sterile signals in the development of alcoholic liver disease. Alcohol Alcohol 2017;52:414-24. [PMID: 28482064 DOI: 10.1093/alcalc/agx025] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
350 González-gonzález JA, García-compean D, Vázquez-elizondo G, Garza-galindo A, Jáquez-quintana JO, Maldonado-garza H. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study. Annals of Hepatology 2011;10:287-95. [DOI: 10.1016/s1665-2681(19)31540-6] [Cited by in Crossref: 33] [Article Influence: 3.0] [Reference Citation Analysis]
351 Ben Abderrahim S, Gharbaoui M, Békir O, Hamdoun M, Allouche M. Sudden death related to the gastrointestinal system in Tunisia: A 13 year autopsy study. J Forensic Sci 2021. [PMID: 34897679 DOI: 10.1111/1556-4029.14953] [Reference Citation Analysis]
352 Jiménez-Sousa MÁ, Gómez-Moreno AZ, Pineda-Tenor D, Medrano LM, Sánchez-Ruano JJ, Fernández-Rodríguez A, Artaza-Varasa T, Saura-Montalban J, Vázquez-Morón S, Ryan P, Resino S. CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study. Clin Transl Med 2017;6:26. [PMID: 28755163 DOI: 10.1186/s40169-017-0156-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
353 Gao R, Gao F, Li G, Hao JY. Health-related quality of life in chinese patients with chronic liver disease. Gastroenterol Res Pract. 2012;2012:516140. [PMID: 22701477 DOI: 10.1155/2012/516140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
354 Mellinger JL, Volk ML. Transplantation for Alcohol-related Liver Disease: Is It Fair? Alcohol Alcohol 2018;53:173-7. [PMID: 29236944 DOI: 10.1093/alcalc/agx105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
355 Chen YP, Jin X, Kong M, Li YM. Pattern of microRNA expression associated with different stages of alcoholic liver disease in rat models. Mol Med Rep 2014;10:1195-204. [PMID: 25017766 DOI: 10.3892/mmr.2014.2368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
356 Singh A, Pandey B. A New Intelligent Medical Decision Support System Based on Enhanced Hierarchical Clustering and Random Decision Forest for the Classification of Alcoholic Liver Damage, Primary Hepatoma, Liver Cirrhosis, and Cholelithiasis. J Healthc Eng 2018;2018:1469043. [PMID: 29599940 DOI: 10.1155/2018/1469043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
357 Imajo K, Toyoda H, Yasuda S, Suzuki Y, Sugimoto K, Kuroda H, Akita T, Tanaka J, Yasui Y, Tamaki N, Kurosaki M, Izumi N, Nakajima A, Kumada T. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01182-4. [PMID: 34768008 DOI: 10.1016/j.cgh.2021.11.003] [Reference Citation Analysis]
358 Wang M, Frasch SC, Li G, Feng D, Gao B, Xu L, Ir D, Frank DN, Bratton DL, Ju C. Role of gp91phox in hepatic macrophage programming and alcoholic liver disease. Hepatol Commun 2017;1:765-79. [PMID: 29404493 DOI: 10.1002/hep4.1078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
359 Rodimova S, Elagin V, Karabut M, Koryakina I, Timin A, Zagainov V, Zyuzin M, Zagaynova E, Kuznetsova D. Toxicological Analysis of Hepatocytes Using FLIM Technique: In Vitro versus Ex Vivo Models. Cells 2021;10:2894. [PMID: 34831114 DOI: 10.3390/cells10112894] [Reference Citation Analysis]
360 Roman S, Zepeda-Carrillo EA, Moreno-Luna LE, Panduro A. Alcoholism and liver disease in Mexico: genetic and environmental factors. World J Gastroenterol. 2013;19:7972-7982. [PMID: 24307790 DOI: 10.3748/wjg.v19.i44.7972.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
361 Guerreiro-Costa LNF, Araújo-Filho JEO, Marback RF, Jesus-Nunes AP, Morais-DE-Jesus M, Quarantini LC. MENTAL DISORDERS AND QUALITY OF LIFE IN PATIENTS AWAITING LIVER TRANSPLANTATION. Arq Gastroenterol 2019;56:339-43. [PMID: 31618394 DOI: 10.1590/S0004-2803.201900000-63] [Reference Citation Analysis]
362 Mathurin P. The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. J Hepatol 2010;53:392-3. [PMID: 20537754 DOI: 10.1016/j.jhep.2010.03.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
363 Innes HA, Hutchinson SJ, Barclay S, Cadzow E, Dillon JF, Fraser A, Goldberg DJ, Mills PR, McDonald SA, Morris J. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology. 2013;57:451-460. [PMID: 22961861 DOI: 10.1002/hep.26051] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
364 Njei B, Do A, McCarty TR, Fortune BE. Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials. J Clin Gastroenterol 2016;50:871-81. [PMID: 27404293 DOI: 10.1097/MCG.0000000000000585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
365 Wieser V, Tilg H. [Management of severe alcoholic hepatitis]. Wien Med Wochenschr 2014;164:3-8. [PMID: 23842647 DOI: 10.1007/s10354-013-0221-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
366 Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F, Restrepo JC, Torre A, Urzua A, Simonetto DA, Abraldes JG, Méndez-Sánchez N, Contreras F, Lucey MR, Shah VH, Cortez-Pinto H, Bataller R. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 2019;18:518-35. [PMID: 31053546 DOI: 10.1016/j.aohep.2019.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
367 Seo B, Jeon K, Moon S, Lee K, Kim W, Jeong H, Cha KH, Lim MY, Kang W, Kweon M, Sung J, Kim W, Park J, Ko G. Roseburia spp. Abundance Associates with Alcohol Consumption in Humans and Its Administration Ameliorates Alcoholic Fatty Liver in Mice. Cell Host & Microbe 2020;27:25-40.e6. [DOI: 10.1016/j.chom.2019.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
368 Goel A, Ramakrishna B, Muliyil J, Madhu K, Sajith KG, Zachariah U, Ramachandran J, Keshava SN, Selvakumar R, Chandy GM, Elias E, Eapen CE. Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis. Dig Dis Sci 2013;58:179-87. [PMID: 22918688 DOI: 10.1007/s10620-012-2361-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
369 Yu J, Peng J, Luan Z, Zheng F, Su W. MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease. Molecules 2019;24:E230. [PMID: 30634538 DOI: 10.3390/molecules24020230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
370 Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. [PMID: 30115921 DOI: 10.1038/s41572-018-0014-7] [Cited by in Crossref: 191] [Cited by in F6Publishing: 195] [Article Influence: 47.8] [Reference Citation Analysis]
371 Cho Y, Park YS, Kim HY, Kim W, Lee HJ, Kim DJ. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial. Trials 2018;19:696. [PMID: 30577864 DOI: 10.1186/s13063-018-3092-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
372 Siddiqui MT, Cresci GAM. Microbiota reprogramming for treatment of alcohol-related liver disease. Transl Res 2020;226:26-38. [PMID: 32687975 DOI: 10.1016/j.trsl.2020.07.004] [Reference Citation Analysis]
373 Khanam A, Kottilil S. Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management. Front Med (Lausanne) 2021;8:752875. [PMID: 34820395 DOI: 10.3389/fmed.2021.752875] [Reference Citation Analysis]
374 Jain M, Venkataraman J, Varghese J, Vij M, Reddy MS, Rela M. Explant liver evaluation decodes the mystery of cryptogenic cirrhosis! JGH Open. 2020;4:39-43. [PMID: 32055695 DOI: 10.1002/jgh3.12200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
375 Lee K, Otgonsuren M, Younoszai Z, Mir HM, Younossi ZM. Association of chronic liver disease with depression: a population-based study. Psychosomatics 2013;54:52-9. [PMID: 23295007 DOI: 10.1016/j.psym.2012.09.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
376 Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160-168. [PMID: 23511777 DOI: 10.1016/j.jhep.2013.03.007] [Cited by in Crossref: 395] [Cited by in F6Publishing: 364] [Article Influence: 43.9] [Reference Citation Analysis]
377 Lazaro R, Wu R, Lee S, Zhu NL, Chen CL, French SW, Xu J, Machida K, Tsukamoto H. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology. 2015;61:129-140. [PMID: 25132354 DOI: 10.1002/hep.27383] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
378 Kai J, Yang X, Wang Z, Wang F, Jia Y, Wang S, Tan S, Chen A, Shao J, Zhang F, Zhang Z, Zheng S. Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Free Radic Biol Med 2020;153:89-102. [PMID: 32289481 DOI: 10.1016/j.freeradbiomed.2020.03.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
379 Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, Trepo C, Mazulli T, Moussa G, Patel A, Baig AA. Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol. 2012;2012:231210. [PMID: 22530132 DOI: 10.1155/2012/231210] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
380 Howarth DL, Yin C, Yeh K, Sadler KC. Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae. Zebrafish 2013;10:199-210. [PMID: 23697887 DOI: 10.1089/zeb.2012.0821] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
381 Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol 2019;70:328-34. [PMID: 30658734 DOI: 10.1016/j.jhep.2018.11.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 24.0] [Reference Citation Analysis]
382 Liu P, Xu Y, Tang Y, Du M, Yu X, Sun J, Xiao L, He M, Wei S, Yuan J, Wang Y, Liang Y, Wu T, Miao X, Yao P. Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men. PLoS One 2017;12:e0181497. [PMID: 28727853 DOI: 10.1371/journal.pone.0181497] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
383 Huang X, Liu X, Yu Y. Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? Front Mol Neurosci 2017;10:134. [PMID: 28533742 DOI: 10.3389/fnmol.2017.00134] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
384 Nanchal R, Subramanian R, Karvellas CJ, Hollenberg SM, Peppard WJ, Singbartl K, Truwit J, Al-khafaji AH, Killian AJ, Alquraini M, Alshammari K, Alshamsi F, Belley-cote E, Cartin-ceba R, Dionne JC, Galusca DM, Huang DT, Hyzy RC, Junek M, Kandiah P, Kumar G, Morgan RL, Morris PE, Olson JC, Sieracki R, Steadman R, Taylor B, Alhazzani W. Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations. Critical Care Medicine 2020;48:e173-91. [DOI: 10.1097/ccm.0000000000004192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
385 Zheng MH, Shi KQ, Fan YC, Liu WY, Lin XF, Li LF, Chen YP. Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population. PLoS One 2012;7:e43736. [PMID: 22962588 DOI: 10.1371/journal.pone.0043736] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
386 Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151-166. [PMID: 33128017 DOI: 10.1038/s41575-020-00372-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 46] [Article Influence: 15.5] [Reference Citation Analysis]
387 Imprialos KP, Stavropoulos K, Doumas M, Skalkou A, Zografou I, Athyros VG. The potential role of statins in treating liver disease. Expert Review of Gastroenterology & Hepatology 2018;12:331-9. [DOI: 10.1080/17474124.2018.1439379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
388 Schulze RJ, Rasineni K, Weller SG, Schott MB, Schroeder B, Casey CA, McNiven MA. Ethanol exposure inhibits hepatocyte lipophagy by inactivating the small guanosine triphosphatase Rab7. Hepatol Commun. 2017;1:140-152. [PMID: 29404450 DOI: 10.1002/hep4.1021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
389 Pan CX, Tang J, Wang XY, Wu FR, Ge JF, Chen FH. Role of interleukin-22 in liver diseases. Inflamm Res. 2014;63:519-525. [PMID: 24623532 DOI: 10.1007/s00011-014-0727-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
390 Marroni CA, Fleck Jr AM, Fernandes SA, Galant LH, Mucenic M, de Mattos Meine MH, Mariante-Neto G, Brandão ABM. Liver transplantation and alcoholic liver disease: History, controversies, and considerations. World J Gastroenterol 2018; 24(26): 2785-2805 [PMID: 30018475 DOI: 10.3748/wjg.v24.i26.2785] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
391 Pavlov CS, Casazza G, Semenistaia M, Nikolova D, Tsochatzis E, Liusina E, Ivashkin VT, Gluud C. Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev. 2016;3:CD011602. [PMID: 26934429 DOI: 10.1002/14651858.cd011602.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
392 Wang QM, Ji Q, Duan ZJ, Zhang M, Chang QY. A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med 2013;6:584-90. [PMID: 24137231 DOI: 10.3892/etm.2013.1137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
393 Molfino A, Johnson S, Medici V. The Challenges of Nutritional Assessment in Cirrhosis. Curr Nutr Rep 2017;6:274-80. [PMID: 29201536 DOI: 10.1007/s13668-017-0216-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
394 Singh L, Joshi T, Tewari D, Echeverría J, Mocan A, Sah AN, Parvanov E, Tzvetkov NT, Ma ZF, Lee YY, Poznański P, Huminiecki L, Sacharczuk M, Jóźwik A, Horbańczuk JO, Feder-Kubis J, Atanasov AG. Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook. Front Pharmacol 2019;10:1593. [PMID: 32116660 DOI: 10.3389/fphar.2019.01593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
395 Morgan TR, Chao D, Botwin G. Treatment of alcoholic hepatitis. Clin Liver Dis (Hoboken) 2013;2:84-8. [PMID: 30992831 DOI: 10.1002/cld.166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
396 Caviglia GP, Armandi A, Rosso C, Gaia S, Aneli S, Rolle E, Abate ML, Olivero A, Nicolosi A, Guariglia M, Ribaldone DG, Carucci P, Saracco GM, Bugianesi E. Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Cancers (Basel) 2021;13:2305. [PMID: 34064999 DOI: 10.3390/cancers13102305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
397 Vergis N, Atkinson SR, Knapp S, Maurice J, Allison M, Austin A, Forrest EH, Masson S, Mccune A, Patch D, Richardson P, Gleeson D, Ryder SD, Wright M, Thursz MR. In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. Gastroenterology 2017;152:1068-1077.e4. [DOI: 10.1053/j.gastro.2016.12.019] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 12.5] [Reference Citation Analysis]
398 Mou HY, Nie HM, Hu XY. Gutuo Jiejiu decoction improves survival of patients with severe alcoholic hepatitis: A retrospective cohort study. World J Gastroenterol 2017; 23(16): 2957-2963 [PMID: 28522913 DOI: 10.3748/wjg.v23.i16.2957] [Reference Citation Analysis]
399 Guan M, Zhao N, Xie K, Zeng T. Hepatoprotective effects of garlic against ethanol-induced liver injury: A mini-review. Food and Chemical Toxicology 2018;111:467-73. [DOI: 10.1016/j.fct.2017.11.059] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
400 Dhanda AD, Collins PL, McCune CA. Is liver biopsy necessary in the management of alcoholic hepatitis? World J Gastroenterol 2013; 19(44): 7825-7829 [PMID: 24307775 DOI: 10.3748/wjg.v19.i44.7825] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
401 Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis. 2015;35:36-42. [PMID: 25632933 DOI: 10.1055/s-0034- 1397347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Pimentel CFMG, Amaral ACC, Gonzalez AM, Lai M, Mota DO, Ferraz MLG, Junior WM, Kondo M. Six-minute walking test performance is associated with survival in cirrhotic patients. World J Hepatol 2021; 13(11): 1791-1801 [PMID: 34904046 DOI: 10.4254/wjh.v13.i11.1791] [Reference Citation Analysis]
403 Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol 2017; 23(36): 6549-6570 [PMID: 29085205 DOI: 10.3748/wjg.v23.i36.6549] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 65] [Article Influence: 16.2] [Reference Citation Analysis]
404 Takeuchi M, Takino JI, Sakasai-Sakai A, Takata T, Tsutsumi M. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Nutrients 2017;9:E634. [PMID: 28632197 DOI: 10.3390/nu9060634] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
405 Elliott C, Frith J, Day CP, Jones DEJ, Newton JL. Functional Impairment in Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease Is Significant and Persists over 3 Years of Follow-Up. Dig Dis Sci 2013;58:2383-91. [DOI: 10.1007/s10620-013-2657-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
406 Parker R, Kim SJ, Im GY, Nahas J, Dhesi B, Vergis N, Sinha A, Ghezzi A, Rink MR, McCune A, Aithal GP, Newsome PN, Weston CJ, Holt A, Gao B. Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine 2019;45:511-8. [PMID: 31278069 DOI: 10.1016/j.ebiom.2019.03.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
407 Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: the gut microbiome and liver cross talk. Alcohol Clin Exp Res. 2015;39:763-775. [PMID: 25872593 DOI: 10.1111/acer.12704] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 21.0] [Reference Citation Analysis]
408 Chung D, Yang M, Li Y, Chen W, Hung C, Wang C. Ganoderma lucidum repress injury of ethanol-induced steatohepatitis via anti-inflammation, anti-oxidation and reducing hepatic lipid in C57BL/6J mice. Journal of Functional Foods 2017;33:314-22. [DOI: 10.1016/j.jff.2017.03.059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
409 Chacko KR, Reinus J. Spectrum of Alcoholic Liver Disease. Clin Liver Dis 2016;20:419-27. [PMID: 27373606 DOI: 10.1016/j.cld.2016.02.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
410 Correnti J, Lin C, Brettschneider J, Kuriakose A, Jeon S, Scorletti E, Oranu A, McIver-Jenkins D, Kaneza I, Buyco D, Saiman Y, Furth EE, Argemi J, Bataller R, Holland WL, Carr RM. Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice. J Lipid Res 2020;61:983-94. [PMID: 32398264 DOI: 10.1194/jlr.RA119000446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
411 Wang Q, Dai X, Yang W, Wang H, Zhao H, Yang F, Yang Y, Li J, Lv X. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. Int Immunopharmacol. 2015;25:340-352. [PMID: 25701503 DOI: 10.1016/j.intimp.2015.02.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
412 Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology. 2013;58:1814-1823. [PMID: 23532958 DOI: 10.1002/hep.26419] [Cited by in Crossref: 172] [Cited by in F6Publishing: 169] [Article Influence: 19.1] [Reference Citation Analysis]
413 Kim W, Kim DJ. Severe alcoholic hepatitis-current concepts, diagnosis and treatment options. World J Hepatol 2014; 6(10): 688-695 [PMID: 25349640 DOI: 10.4254/wjh.v6.i10.688] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
414 Hamarneh SR, Kim BM, Kaliannan K, Morrison SA, Tantillo TJ, Tao Q, Mohamed MMR, Ramirez JM, Karas A, Liu W, Hu D, Teshager A, Gul SS, Economopoulos KP, Bhan AK, Malo MS, Choi MY, Hodin RA. Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice. Dig Dis Sci 2017;62:2021-34. [PMID: 28424943 DOI: 10.1007/s10620-017-4576-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
415 Ren Y, Geng Y, Chen H, Lu Z, Shi J, Xu Z. Polysaccharide peptides from Coriolus versicolor: A multi-targeted approach for the protection or prevention of alcoholic liver disease. Journal of Functional Foods 2018;40:769-77. [DOI: 10.1016/j.jff.2017.11.051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
416 Vatsalya V, Kong M, Cave MC, Liu N, Schwandt ML, George DT, Ramchandani VA, McClain CJ. Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients. J Nutr Biochem. 2018;59:49-55. [PMID: 29960116 DOI: 10.1016/j.jnutbio.2018.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
417 Singal AK, Kamath PS, Gores GJ, Shah VH. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol 2014;12:555-64; quiz e31-2. [PMID: 23811249 DOI: 10.1016/j.cgh.2013.06.013] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 9.9] [Reference Citation Analysis]
418 Shi X, Sun R, Zhao Y, Fu R, Wang R, Zhao H, Wang Z, Tang F, Zhang N, Tian X, Yao J. Promotion of autophagosome–lysosome fusion via salvianolic acid A-mediated SIRT1 up-regulation ameliorates alcoholic liver disease. RSC Adv 2018;8:20411-22. [DOI: 10.1039/c8ra00798e] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
419 Ho SB, Matheny ME, Schnabl BE. Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health Systems. Gut Liver 2016;10:8-9. [PMID: 26696026 DOI: 10.5009/gnl15593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
420 Wang Z, Dou X, Li S, Zhang X, Sun X, Zhou Z, Song Z. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice. Hepatology. 2014;59:1381-1392. [PMID: 24170703 DOI: 10.1002/hep.26912] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
421 Hong SK, Yi NJ, Kim HS, Ahn SW, Yoon KC, Kim H, Lee KW, Suh KS. Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation. J Korean Med Sci 2017;32:919-25. [PMID: 28480648 DOI: 10.3346/jkms.2017.32.6.919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
422 Dasarathy S, Mitchell MC, Barton B, McClain CJ, Szabo G, Nagy LE, Radaeva S, McCullough AJ. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. Contemp Clin Trials 2020;96:106094. [PMID: 32739495 DOI: 10.1016/j.cct.2020.106094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
423 Lizarazo D, Zabala V, Tong M, Longato L, de la Monte SM. Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis. J Gastroenterol Hepatol 2013;28:1660-8. [PMID: 23802886 DOI: 10.1111/jgh.12291] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
424 Gimenes FR, Reis RK, da Silva PC, Silva AE, Atila E. Nursing Assessment Tool for People With Liver Cirrhosis. Gastroenterol Nurs 2016;39:264-72. [PMID: 26425862 DOI: 10.1097/SGA.0000000000000153] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
425 Papastergiou V, Burroughs AK, Tsochatzis EA. Prognosis and treatment of patients with acute alcoholic hepatitis. Expert Rev Gastroenterol Hepatol. 2014;8:471-486. [PMID: 24716632 DOI: 10.1586/17474124.2014.903800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
426 Amjad W, Alukal J, Doycheva I, Zhang T, Maheshwari A, Yoo H, Thuluvath PJ. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis. Dig Dis Sci 2020;65:3726-33. [DOI: 10.1007/s10620-020-06142-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
427 Mandrekar P, Bataller R, Tsukamoto H, Gao B. Alcoholic hepatitis: Translational approaches to develop targeted therapies. Hepatology. 2016;64:1343-1355. [PMID: 26940353 DOI: 10.1002/hep.28530] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 10.3] [Reference Citation Analysis]
428 Fagan KJ, Irvine KM, Kumar S, Bates A, Horsfall LU, Feeney GF, Powell EE. Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention: Assessment of alcohol in liver disease. Intern Med J 2013;43:1096-102. [DOI: 10.1111/imj.12229] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
429 Rudler M, Mouri S, Charlotte F, Lebray P, Capocci R, Benosman H, Poynard T, Thabut D. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding. Journal of Hepatology 2015;62:816-21. [DOI: 10.1016/j.jhep.2014.11.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
430 Gupta H, Suk KT, Kim DJ. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. J Clin Med 2021;10:541. [PMID: 33540624 DOI: 10.3390/jcm10030541] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
431 Li W, Lin EL, Liangpunsakul S, Lan J, Chalasani S, Rane S, Puri P, Kamath PS, Sanyal AJ, Shah VH, Radaeva S, Crabb DW, Chalasani N, Yu Q. Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis. Clin Transl Gastroenterol. 2019;10:e00052. [PMID: 31211759 DOI: 10.14309/ctg.0000000000000052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
432 Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: A review and a point of view. World J Gastroenterol 2014; 20(43): 15943-15954 [PMID: 25473148 DOI: 10.3748/wjg.v20.i43.15943] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
433 Blake L, Duarte RV, Cummins C. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging. BMJ Open 2016;6:e010507. [PMID: 27650757 DOI: 10.1136/bmjopen-2015-010507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
434 Gillessen A, Schmidt HH. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther 2020;37:1279-301. [PMID: 32065376 DOI: 10.1007/s12325-020-01251-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
435 Xu P, Xu CF, Wan XY, Yu CH, Shen C, Chen P, Xu GY, Li YM. Association between serum alpha-fetoprotein levels and fatty liver disease: A cross-sectional study. World J Gastroenterol 2014; 20(33): 11865-11870 [PMID: 25206293 DOI: 10.3748/wjg.v20.i33.11865] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
436 Shipley LC, Kodali S, Singal AK. Recent updates on alcoholic hepatitis. Dig Liver Dis 2019;51:761-8. [PMID: 31010745 DOI: 10.1016/j.dld.2019.03.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
437 Spengler EK, Dunkelberg J, Schey R. Alcoholic hepatitis: current management. Dig Dis Sci. 2014;59:2357-2366. [PMID: 24798996 DOI: 10.1007/s10620-014-3173-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
438 Ramirez T, Tong M, Chen WC, Nguyen QG, Wands JR, de la Monte SM. Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatment. J Gastroenterol Hepatol 2013;28:179-87. [PMID: 22988930 DOI: 10.1111/j.1440-1746.2012.07256.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
439 Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis 2015;35:36-42. [PMID: 25632933 DOI: 10.1055/s-0034-1397347] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
440 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [DOI: 10.1002/hep.30866] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 58.5] [Reference Citation Analysis]
441 Gogineni H, Aranda JP, Garavalia LS. Designing professional program instruction to align with students' cognitive processing. Curr Pharm Teach Learn 2019;11:160-5. [PMID: 30733012 DOI: 10.1016/j.cptl.2018.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
442 Kim SH, Kim BG, Kim W, Oh S, Kim HY, Jung YJ, Jeong JB, Kim JW, Lee KL. Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis: GI hemorrhage in alcoholic hepatitis. Journal of Gastroenterology and Hepatology 2016;31:814-21. [DOI: 10.1111/jgh.13220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
443 Ramos-lopez O, Roman S, Martinez-lopez E, Gonzalez-aldaco K, Ojeda-granados C, Sepulveda-villegas M, Panduro A. Association of a novel TAS2R38 haplotype with alcohol intake among Mexican-Mestizo population. Annals of Hepatology 2015;14:729-34. [DOI: 10.1016/s1665-2681(19)30768-9] [Cited by in Crossref: 21] [Article Influence: 3.0] [Reference Citation Analysis]
444 Rahimi E, Pan JJ. Prognostic models for alcoholic hepatitis. Biomark Res 2015;3:20. [PMID: 26203357 DOI: 10.1186/s40364-015-0046-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
445 Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C. [Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)]. Ter Arkh 2019;91:52-66. [PMID: 32598755 DOI: 10.26442/00403660.2019.08.000354] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
446 Pérez-Hernández O, González-Reimers E, Quintero-Platt G, Abreu-González P, Vega-Prieto MJ, Sánchez-Pérez MJ, Martín-González C, Martínez-Riera A, Santolaria-Fernández F. Malondialdehyde as a Prognostic Factor in Alcoholic Hepatitis. Alcohol Alcohol 2017;52:305-10. [PMID: 28007738 DOI: 10.1093/alcalc/agw094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
447 Mcgrath E, Armitage CJ, Mckie S, Millar T, Ab-Ghani A, Elliott R. Evidence That Implementation Intentions Enhance Cognitive Training and Reduce Alcohol Consumption in Heavy Drinkers: A Randomized Trial. Ann Behav Med 2020;54:391-401. [PMID: 31819947 DOI: 10.1093/abm/kaz056] [Reference Citation Analysis]
448 Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97:492-510. [PMID: 25217800 DOI: 10.1016/j.yexmp.2014.09.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
449 Farooq MO, Bataller R. Pathogenesis and Management of Alcoholic Liver Disease. Dig Dis 2016;34:347-55. [PMID: 27170388 DOI: 10.1159/000444545] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
450 Chinese Society of Hepatology, Chinese Society of Gastroenterology, and Chinese Society of Infectious Diseases of the Chinese Medical Association. Consensus on the diagnosis and treatment of cholestatic liver diseases (2015, China). J Dig Dis 2016;17:137-54. [PMID: 26950044 DOI: 10.1111/1751-2980.12333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
451 Yang W, Huang L, Gao J, Wen S, Tai Y, Chen M, Huang Z, Liu R, Tang C, Li J. Betaine attenuates chronic alcohol-induced fatty liver by broadly regulating hepatic lipid metabolism. Mol Med Rep. 2017;16:5225-5234. [PMID: 28849079 DOI: 10.3892/mmr.2017.7295] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
452 Cucchetti A, Cescon M, Trevisani F, Pinna AD. Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients. World J Gastroenterol 2012; 18(44): 6398-6408 [PMID: 23197885 DOI: 10.3748/wjg.v18.i44.6398] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
453 Gopal T, Kumar N, Perriotte-Olson C, Casey CA, Donohue TM Jr, Harris EN, Talmon G, Kabanov AV, Saraswathi V. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver. Am J Physiol Gastrointest Liver Physiol. 2020;318:G428-G438. [PMID: 31928222 DOI: 10.1152/ajpgi.00217.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
454 Kim W. [Diagnostic and therapeutic strategies for severe alcoholic hepatitis]. Korean J Gastroenterol 2015;65:4-11. [PMID: 25603848 DOI: 10.4166/kjg.2015.65.1.4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
455 Fuster D, García-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol 2021; 27(23): 3223-3237 [PMID: 34163107 DOI: 10.3748/wjg.v27.i23.3223] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Chao A, Waitzberg D, de Jesus RP, Bueno AA, Kha V, Allen K, Kappus M, Medici V. Malnutrition and Nutritional Support in Alcoholic Liver Disease: a Review. Curr Gastroenterol Rep. 2016;18:65. [PMID: 27787787 DOI: 10.1007/s11894-016-0539-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
457 Buzzetti E, Parikh PM, Gerussi A, Tsochatzis E. Gender differences in liver disease and the drug-dose gender gap. Pharmacol Res 2017;120:97-108. [PMID: 28336373 DOI: 10.1016/j.phrs.2017.03.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
458 Saha B, Momen-Heravi F, Kodys K, Szabo G. MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages. J Biol Chem. 2016;291:149-159. [PMID: 26527689 DOI: 10.1074/jbc.m115.694133] [Cited by in Crossref: 111] [Cited by in F6Publishing: 74] [Article Influence: 15.9] [Reference Citation Analysis]
459 Orman ES, Odena G, Bataller R. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol. 2013;28 Suppl 1:77-84. [PMID: 23855300 DOI: 10.1111/jgh.12030] [Cited by in Crossref: 144] [Cited by in F6Publishing: 138] [Article Influence: 18.0] [Reference Citation Analysis]
460 Hashimoto E, Tokushige K, Ludwig J. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges. Hepatol Res. 2015;45:20-28. [PMID: 24661406 DOI: 10.1111/hepr.12333] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
461 Cheng Q, Li YW, Yang CF, Zhong YJ, He H, Zhu FC, Li L. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells. Chem Biol Interact 2018;291:180-9. [PMID: 29940154 DOI: 10.1016/j.cbi.2018.06.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
462 Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20(33): 11684-11699 [PMID: 25206273 DOI: 10.3748/wjg.v20.i33.11684] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
463 Ibusuki R, Uto H, Oda K, Ohshige A, Tabu K, Mawatari S, Kumagai K, Kanmura S, Tamai T, Moriuchi A, Tsubouchi H, Ido A. Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.PLoS One. 2017;12:e0174913. [PMID: 28403148 DOI: 10.1371/journal.pone.0174913] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
464 Vorobioff JD, Groszmann RJ. Prevention of portal hypertension: from variceal development to clinical decompensation. Hepatology. 2015;61:375-381. [PMID: 24913395 DOI: 10.1002/hep.27249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
465 Basra S, Anand BS. Definition, epidemiology and magnitude of alcoholic hepatitis. World J Hepatol 2011; 3(5): 108-113 [PMID: 21731902 DOI: 10.4254/wjh.v3.i5.108] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
466 Laitakari A, Ollonen T, Kietzmann T, Walkinshaw G, Mennerich D, Izzi V, Haapasaari KM, Myllyharju J, Serpi R, Dimova EY, Koivunen P. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease. Redox Biol 2019;22:101145. [PMID: 30802717 DOI: 10.1016/j.redox.2019.101145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
467 Li J, Wang Z, Qiu W, Yang JJ, Wang Q, Chen S, Pan H. The effect of interaction between EtOH dosage and exposure time on gene expression in DPSC. Genomics 2019;111:500-7. [PMID: 29596963 DOI: 10.1016/j.ygeno.2018.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
468 Wang H, Tan T, Wang J, Niu Y, Yan Y, Guo X, Kang Y, Duan Y, Chang S, Liao J, Si C, Ji W, Si W. Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis. Sci Rep 2015;5:15019. [PMID: 26442469 DOI: 10.1038/srep15019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
469 Berger D, Bradley KA. Primary Care Management of Alcohol Misuse. Med Clin North Am 2015;99:989-1016. [PMID: 26320043 DOI: 10.1016/j.mcna.2015.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
470 Pang JX, Ross E, Borman MA, Zimmer S, Kaplan GG, Heitman SJ, Swain MG, Burak KW, Quan H, Myers RP. Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data. BMC Gastroenterol 2015;15:116. [PMID: 26362871 DOI: 10.1186/s12876-015-0348-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
471 Dugum MF, McCullough AJ. Acute Alcoholic Hepatitis, the Clinical Aspects. Clin Liver Dis 2016;20:499-508. [PMID: 27373612 DOI: 10.1016/j.cld.2016.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
472 Chang B, Li B, Sun Y, Teng G, Huang A, Li J, Zou Z. Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013. Mediators Inflamm 2017;2017:5605981. [PMID: 29358850 DOI: 10.1155/2017/5605981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
473 Heslin KC, Elixhauser A, Steiner CA. Identifying in-patient costs attributable to the clinical sequelae and comorbidities of alcoholic liver disease in a national hospital database. Addiction 2017;112:782-91. [PMID: 27886658 DOI: 10.1111/add.13702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
474 Goh ET, Morgan MY. Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Aliment Pharmacol Ther 2017;45:865-82. [DOI: 10.1111/apt.13965] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
475 Lu C, Xu W, Shao J, Zhang F, Chen A, Zheng S. Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes. Toxicol Sci 2017;155:432-43. [DOI: 10.1093/toxsci/kfw228] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
476 Tu Y, Zhu S, Wang J, Burstein E, Jia D. Natural compounds in the chemoprevention of alcoholic liver disease. Phytother Res 2019;33:2192-212. [PMID: 31264302 DOI: 10.1002/ptr.6410] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
477 Ehala-aleksejev K, Punab M. Serum hepatic enzyme activity in relation to semen quality and serum reproductive hormone levels among Estonian fertile Men. Andrology 2016;4:152-9. [DOI: 10.1111/andr.12136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
478 Bedossa P, Kleiner DE. Pathology of Alcoholic and Nonalcoholic Fatty Liver Disease. In: Chalasani N, Szabo G, editors. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing; 2016. pp. 223-47. [DOI: 10.1007/978-3-319-20538-0_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
479 Kuo MT, Yang SC, Lu LS, Hsu CN, Kuo YH, Kuo CH, Liang CM, Kuo CM, Wu CK, Tai WC, Chuah SK. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease. BMC Gastroenterol 2015;15:61. [PMID: 26268474 DOI: 10.1186/s12876-015-0289-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
480 Kim YG, Park GM, Lee SB, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics. Sci Rep 2020;10:17994. [PMID: 33093619 DOI: 10.1038/s41598-020-75078-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
481 Kim W, Jeong D, Chung J, Lee D, Joo S, Jang ES, Choi YJ, Yoon H, Shin CM, Park YS, Jeong SH, Kim N, Lee DH, Kim JW. Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study. Sci Rep 2019;9:3236. [PMID: 30824851 DOI: 10.1038/s41598-019-39573-9] [Reference Citation Analysis]
482 Szabo G, Zakhari S. Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients. World J Gastroenterol 2011; 17(20): 2500-2506 [PMID: 21633654 DOI: 10.3748/wjg.v17.i20.2500] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
483 Rachakonda V, Gabbert C, Raina A, Li H, Malik S, DeLany JP, Behari J. Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines. Alcohol Clin Exp Res. 2014;38:2712-2721. [PMID: 25421508 DOI: 10.1111/acer.12558] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
484 Thompson J, Jones N, Al-Khafaji A, Malik S, Reich D, Munoz S, MacNicholas R, Hassanein T, Teperman L, Stein L. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018;24:380-393. [PMID: 29171941 DOI: 10.1002/lt.24986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
485 Zuluaga P, Sanvisens A, Teniente A, Fuster D, Tor J, Martínez-cáceres E, Muga R. Wide array of T-cell subpopulation alterations in patients with alcohol use disorders. Drug and Alcohol Dependence 2016;162:124-9. [DOI: 10.1016/j.drugalcdep.2016.02.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
486 Salehi E, Mashayekh M, Taheri F, Gholami M, Motaghinejad M, Safari S, Sepehr A. Curcumin Can be Acts as Effective agent for Prevent or Treatment of Alcohol-induced Toxicity in Hepatocytes: An Illustrated Mechanistic Review. Iran J Pharm Res 2021;20:418-36. [PMID: 34400970 DOI: 10.22037/ijpr.2020.112852.13985] [Reference Citation Analysis]
487 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19:216-254. [PMID: 24133661 DOI: 10.3350/cmh.2013.19.3.216] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
488 Liu G, Zhang Y, Liu C, Xu D, Zhang R, Cheng Y, Pan Y, Huang C, Chen Y. Luteolin Alleviates Alcoholic Liver Disease Induced by Chronic and Binge Ethanol Feeding in Mice. The Journal of Nutrition 2014;144:1009-15. [DOI: 10.3945/jn.114.193128] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
489 García Buey L, González Mateos F, Moreno-otero R. Cirrosis hepática. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:625-33. [DOI: 10.1016/s0304-5412(12)70359-1] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
490 Hong K, Yun S, Cho J, Lee D, Ji S, Son J, Kim E. Silkworm ( Bombyx mori ) powder supplementation alleviates alcoholic fatty liver disease in rats. Journal of Functional Foods 2018;43:29-36. [DOI: 10.1016/j.jff.2018.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
491 Piechota M, Piechota A, Misztal M, Bernas S, Pietraszek-Grzywaczewska I. An evaluation of the usefulness of extracorporeal liver support techniques in patients with severe liver dysfunction. Arch Med Sci. 2019;15:99-112. [PMID: 30697259 DOI: 10.5114/aoms.2017.67998] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
492 Gonçalves JL, Lacerda-queiroz N, Sabino JF, Marques PE, Galvão I, Gamba CO, Cassali GD, de Carvalho LM, da Silva e Silva DA, Versiani A, Teixeira MM, de Faria AMC, Vieira AT, Brunialti-godard AL. Evaluating the effects of refined carbohydrate and fat diets with acute ethanol consumption using a mouse model of alcoholic liver injury. The Journal of Nutritional Biochemistry 2017;39:93-100. [DOI: 10.1016/j.jnutbio.2016.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
493 Wu W, Zhu B, Peng X, Zhou M, Jia D, Gu J. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Biochem Biophys Res Commun. 2014;443:68-73. [PMID: 24269813 DOI: 10.1016/j.bbrc.2013.11.057] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
494 Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am. 2011;40:611-639. [PMID: 21893277 DOI: 10.1016/j.gtc.2011.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
495 Tian L, Deshmukh A, Prasad N, Jang YY. Alcohol Increases Liver Progenitor Populations and Induces Disease Phenotypes in Human IPSC-Derived Mature Stage Hepatic Cells. Int J Biol Sci 2016;12:1052-62. [PMID: 27570479 DOI: 10.7150/ijbs.15811] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
496 Vonghia L, Van Herck MA, Weyler J, Francque S. Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease. Front Immunol 2019;10:563. [PMID: 30972062 DOI: 10.3389/fimmu.2019.00563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
497 Leggio L, Lee MR. Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease. Am J Med. 2017;130:124-134. [PMID: 27984008 DOI: 10.1016/j.amjmed.2016.10.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
498 Bass S, Zook N. Intravenous acetylcysteine for indications other than acetaminophen overdose. Am J Health Syst Pharm 2013;70:1496-501. [PMID: 23943180 DOI: 10.2146/ajhp120645] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
499 Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF): Prognostic scores in ACLF. Journal of Digestive Diseases 2013;14:484-90. [DOI: 10.1111/1751-2980.12074] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
500 Carr RM, Dhir R, Yin X, Agarwal B, Ahima RS. Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice. Alcohol Clin Exp Res. 2013;37:1091-1099. [PMID: 23398239 DOI: 10.1111/acer.12075] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
501 Daswani R, Kumar A, Anikhindi SA, Sharma P, Singla V, Bansal N, Arora A. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India. Indian J Gastroenterol 2018;37:141-52. [PMID: 29704174 DOI: 10.1007/s12664-018-0842-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
502 Mellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, Volk ML, Blow FC, Lok ASF. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018;68:872-882. [PMID: 29579356 DOI: 10.1002/hep.29887] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 20.8] [Reference Citation Analysis]
503 Ramirez T, Li YM, Yin S, Xu MJ, Feng D, Zhou Z, Zang M, Mukhopadhyay P, Varga ZV, Pacher P, Gao B, Wang H. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression. J Hepatol 2017;66:601-9. [PMID: 27871879 DOI: 10.1016/j.jhep.2016.11.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 9.2] [Reference Citation Analysis]
504 Sahara K, Paredes AZ, Mehta R, Hyer JM, Tsilimigras DI, Merath K, Farooq SA, Wu L, Moro A, Beal EW, Endo I, Pawlik TM. Potential disease burden of patients with substance abuse undergoing major abdominal surgery: A propensity score-matched analysis. Surgery 2019;166:1181-7. [PMID: 31378476 DOI: 10.1016/j.surg.2019.06.018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
505 Melas N, Haji Younes A, Magnusson P. A case of fatal cutaneous caput medusae hemorrhage. Clin Case Rep 2019;7:452-5. [PMID: 30899470 DOI: 10.1002/ccr3.1996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
506 Lv X, Chen Z, Li J, Zhang L, Liu H, Huang C, Zhu P. Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflamm Res. 2010;59:635-645. [PMID: 20221667 DOI: 10.1007/s00011-010-0176-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
507 Ramirez T, Tong M, Ayala CA, Monfils PR, McMillan PN, Zabala V, Wands JR, de la Monte SM. Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced Steatohepatitis. J Clin Exp Pathol 2012;2:114. [PMID: 26339530 DOI: 10.4172/2161-0681.1000114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
508 Addolorato G, Abenavoli L, Dallio M, Federico A, Germani G, Gitto S, Leandro G, Loguercio C, Marra F, Stasi E. Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2020;52:374-91. [PMID: 32001151 DOI: 10.1016/j.dld.2019.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
509 Li N, Yamamoto G, Fuji H, Kisseleva T. Interleukin-17 in Liver Disease Pathogenesis. Semin Liver Dis 2021. [PMID: 34130335 DOI: 10.1055/s-0041-1730926] [Reference Citation Analysis]
510 Gill HE, Lisanti CJ, Schwope RB, Kim J, Katz M, Harrison S. Technical success rate of MR elastography in a population without known liver disease. Abdom Radiol (NY) 2021;46:590-6. [PMID: 32772122 DOI: 10.1007/s00261-020-02652-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
511 Xiao J, Zhang R, Zhou Q, Liu L, Huang F, Deng Y, Ma Y, Wei Z, Tang X, Zhang M. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Provides Protection against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Intestinal Barrier Dysfunction, and Liver Inflammation. J Agric Food Chem 2017;65:9675-84. [PMID: 29041775 DOI: 10.1021/acs.jafc.7b03791] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
512 Cui Y, Ye Q, Wang H, Li Y, Xia X, Yao W, Qian H. Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice. Arch Pharm Res 2014;37:1624-33. [DOI: 10.1007/s12272-014-0370-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
513 Fung P, Pyrsopoulos N. Emerging concepts in alcoholic hepatitis. World J Hepatol 2017; 9(12): 567-585 [PMID: 28515843 DOI: 10.4254/wjh.v9.i12.567] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
514 McCullough AJ, O’Shea RS, Dasarathy S. Diagnosis and management of alcoholic liver disease. J Dig Dis. 2011;12:257-262. [PMID: 21091932 DOI: 10.1111/j.1751-2980.2010.00470.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
515 Barron KA, Jeffries KA, Krupenko NI. Sphingolipids and the link between alcohol and cancer. Chem Biol Interact 2020;322:109058. [PMID: 32171848 DOI: 10.1016/j.cbi.2020.109058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
516 Yang L, Chen Y, Pan W, Wang H, Li N, Tang B. Visualizing the Conversion Process of Alcohol-Induced Fatty Liver to Steatohepatitis in Vivo with a Fluorescent Nanoprobe. Anal Chem 2017;89:6196-201. [DOI: 10.1021/acs.analchem.7b01144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
517 Lounis MA, Escoula Q, Veillette C, Bergeron KF, Ntambi JM, Mounier C. SCD1 deficiency protects mice against ethanol-induced liver injury. Biochim Biophys Acta 2016;1861:1662-70. [PMID: 27477676 DOI: 10.1016/j.bbalip.2016.07.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
518 Lee Y, Kwon DJ, Kim YH, Ra M, Heo SI, Ahn WG, Park JR, Lee SR, Kim KH, Kim SY. HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice. PLoS One 2017;12:e0185134. [PMID: 29091708 DOI: 10.1371/journal.pone.0185134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
519 Zheng K, Cubero FJ, Nevzorova YA. c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. Genes (Basel) 2017;8:E123. [PMID: 28422055 DOI: 10.3390/genes8040123] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
520 Thompson JA, Martinson N, Martinson M. Mortality and costs associated with alcoholic hepatitis: A claims analysis of a commercially insured population. Alcohol 2018;71:57-63. [DOI: 10.1016/j.alcohol.2018.02.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
521 Yuan Q, Hou S, Zhai J, Tian T, Wu Y, Wu Z, He J, Chen Z, Zhang J. S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver. J Mol Med (Berl) 2019;97:1399-412. [PMID: 31321478 DOI: 10.1007/s00109-019-01808-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
522 van der Heide D, Weiskirchen R, Bansal R. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases. Front Immunol 2019;10:2852. [PMID: 31849997 DOI: 10.3389/fimmu.2019.02852] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
523 Kasztelan-Szczerbinska B, Slomka M, Celinski K, Szczerbinski M. Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int. 2013;2013:614081. [PMID: 24151614 DOI: 10.1155/2013/614081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
524 Zhao L, Wang Y, Liu J, Wang K, Guo X, Ji B, Wu W, Zhou F. Protective Effects of Genistein and Puerarin against Chronic Alcohol-Induced Liver Injury in Mice via Antioxidant, Anti-inflammatory, and Anti-apoptotic Mechanisms. J Agric Food Chem 2016;64:7291-7. [DOI: 10.1021/acs.jafc.6b02907] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
525 Liu L, Xie B, Fan M, Candas-Green D, Jiang JX, Wei R, Wang Y, Chen HW, Hu Y, Li JJ. Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade. Dev Cell 2020;52:196-209.e9. [PMID: 31866205 DOI: 10.1016/j.devcel.2019.11.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
526 Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med. 2015;13:261. [PMID: 26264599 DOI: 10.1186/s12967-015-0623-9] [Cited by in Crossref: 160] [Cited by in F6Publishing: 160] [Article Influence: 22.9] [Reference Citation Analysis]
527 Piechota M, Piechota A. An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease. Hepat Mon. 2016;16:e34127. [PMID: 27642344 DOI: 10.5812/hepatmon.34127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
528 Wang X, Liu M, Zhang C, Li S, Yang Q, Zhang J, Gong Z, Han J, Jia L. Antioxidant Activity and Protective Effects of Enzyme-Extracted Oudemansiella radiata Polysaccharides on Alcohol-Induced Liver Injury. Molecules 2018;23:E481. [PMID: 29473842 DOI: 10.3390/molecules23020481] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
529 Bale G, Vishnubhotla RV, Mitnala S, Sharma M, Padaki RN, Pawar SC, Duvvur RN. Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease. J Clin Exp Hepatol 2019;9:561-8. [PMID: 31695245 DOI: 10.1016/j.jceh.2019.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
530 Wang M, Sun J, Jiang Z, Xie W, Zhang X. Hepatoprotective effect of kaempferol against alcoholic liver injury in mice. Am J Chin Med 2015;43:241-54. [PMID: 25787296 DOI: 10.1142/S0192415X15500160] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
531 Sookoian S, Pirola CJ. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. PLoS One. 2013;8:e58895. [PMID: 23516571 DOI: 10.1371/journal.pone.0058895] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
532 Xiao J, Zhang R, Wu Y, Wu C, Jia X, Dong L, Liu L, Chen Y, Bai Y, Zhang M. Rice Bran Phenolic Extract Protects against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Barrier Dysfunction, and Liver Inflammation Mediated by the Endotoxin–TLR4–NF-κB Pathway. J Agric Food Chem 2020;68:1237-47. [DOI: 10.1021/acs.jafc.9b04961] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
533 Donepudi AC, Ferrell JM, Boehme S, Choi HS, Chiang JYL. Deficiency of cholesterol 7α-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice. Hepatol Commun 2018;2:99-112. [PMID: 29404516 DOI: 10.1002/hep4.1129] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
534 Lee YS, Kim HJ, Kim JH, Yoo YJ, Kim TS, Kang SH, Suh SJ, Joo MK, Jung YK, Lee BJ, Seo YS, Yim HJ, Yeon JE, Kim JS, Park JJ, Um SH, Bak YT, Byun KS. Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2017;51:364-77. [PMID: 27636406 DOI: 10.1097/MCG.0000000000000674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
535 Gomez-Moreno AZ, Pineda-Tenor D, Jimenez-Sousa MA, Sánchez-Ruano JJ, Artaza-Varasa T, Saura-Montalban J, Ryan P, Resino S. Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study. PLoS One 2017;12:e0184404. [PMID: 28880930 DOI: 10.1371/journal.pone.0184404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
536 Carr RM, Correnti J. Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci. 2015;1353:1-20. [PMID: 25998863 DOI: 10.1111/nyas.12787] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
537 Jiang D. Care of chronic liver disease. Prim Care 2011;38:483-98; viii-ix. [PMID: 21872093 DOI: 10.1016/j.pop.2011.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
538 Xu J, Liu X, Gao B, Karin M, Tsukamoto H, Brenner D, Kisseleva T. New Approaches for Studying Alcoholic Liver Disease. Curr Pathobiol Rep 2014;2:171-83. [PMID: 26594598 DOI: 10.1007/s40139-014-0053-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
539 Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C. Glucocorticosteroids for people with alcoholic hepatitis. Cochrane Database Syst Rev 2017;11:CD001511. [PMID: 29096421 DOI: 10.1002/14651858.CD001511.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
540 Caputo F, Domenicali M, Bernardi M. Diagnosis and Treatment of Alcohol Use Disorder in Patients With End-Stage Alcoholic Liver Disease. Hepatology 2019;70:410-7. [PMID: 30471136 DOI: 10.1002/hep.30358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
541 Louvet A, Thursz MR, Kim DJ, Labreuche J, Atkinson SR, Sidhu SS, O’grady JG, Akriviadis E, Sinakos E, Carithers RL, Ramond M, Maddrey WC, Morgan TR, Duhamel A, Mathurin P. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual Data From Controlled Trials. Gastroenterology 2018;155:458-468.e8. [DOI: 10.1053/j.gastro.2018.05.011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 18.0] [Reference Citation Analysis]
542 Lin JN, Chang LL, Lai CH, Lin KJ, Lin MF, Yang CH, Lin HH, Chen YH. Development of an Animal Model for Alcoholic Liver Disease in Zebrafish. Zebrafish 2015;12:271-80. [PMID: 25923904 DOI: 10.1089/zeb.2014.1054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
543 Wang M, Shen G, Xu L, Liu X, Brown JM, Feng D, Ross RA, Gao B, Liangpunsakul S, Ju C. IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages. Journal of Hepatology 2018;68:109-17. [DOI: 10.1016/j.jhep.2017.08.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
544 Miyashima Y, Shibata M, Honma Y, Matsuoka H, Hiura M, Abe S, Harada M. Severe Alcoholic Hepatitis Effectively Treated with Vitamin E as an Add-on to Corticosteroids. Intern Med 2017;56:3293-7. [PMID: 29021453 DOI: 10.2169/internalmedicine.8767-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
545 Sun X, Luo W, Tan X, Li Q, Zhao Y, Zhong W, Sun X, Brouwer C, Zhou Z. Increased plasma corticosterone contributes to the development of alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2013;305:G849-61. [PMID: 24113770 DOI: 10.1152/ajpgi.00139.2013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
546 Zhao H, Lan Y, Liu H, Zhu Y, Liu W, Zhang J, Jia L. Antioxidant and Hepatoprotective Activities of Polysaccharides from Spent Mushroom Substrates (Laetiporus sulphureus) in Acute Alcohol-Induced Mice. Oxid Med Cell Longev 2017;2017:5863523. [PMID: 29430281 DOI: 10.1155/2017/5863523] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
547 Nie X, Zhu Y, Fu H, Dai J, Gao J. The "Dark Side" Effects of Social Capital on Harmful Drinking among Chinese Community Residents: A Multilevel Study. Int J Environ Res Public Health 2018;15:E2249. [PMID: 30326561 DOI: 10.3390/ijerph15102249] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
548 Jadzic J, Cvetkovic D, Milovanovic P, Tomanovic N, Zivkovic V, Nikolic S, Djuric M, Djonic D. The micro-structural analysis of lumbar vertebrae in alcoholic liver cirrhosis. Osteoporos Int 2020;31:2209-17. [DOI: 10.1007/s00198-020-05509-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
549 Ju C, Colgan SP, Eltzschig HK. Hypoxia-inducible factors as molecular targets for liver diseases. J Mol Med (Berl). 2016;94:613-627. [PMID: 27094811 DOI: 10.1007/s00109-016-1408-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 10.8] [Reference Citation Analysis]
550 Abenavoli L, Milic N, Rouabhia S, Addolorato G. Pharmacotherapy of acute alcoholic hepatitis in clinical practice. World J Gastroenterol 2014; 20(9): 2159-2167 [PMID: 24605014 DOI: 10.3748/wjg.v20.i9.2159] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
551 Forsyth CB, Voigt RM, Shaikh M, Tang Y, Cederbaum AI, Turek FW, Keshavarzian A. Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability. Am J Physiol Gastrointest Liver Physiol. 2013;305:G185-G195. [PMID: 23660503 DOI: 10.1152/ajpgi.00354.2012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
552 Carmo RF, Cavalcanti MS, Moura P. Role of Interleukin-22 in chronic liver injury. Cytokine 2017;98:107-14. [DOI: 10.1016/j.cyto.2016.08.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
553 Kim TH, Ku DH, Um SH, Lee HA, Park SW, Chang JM, Yim SY, Suh SJ, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Ahn H. How can we improve the performance of Model for End-Stage Liver Disease sodium score in patients with hepatitis B virus-related decompensated liver cirrhosis commencing antiviral treatment?: Revised MELDNa score for HBV-decompensated LC. Journal of Gastroenterology and Hepatology 2018;33:1641-8. [DOI: 10.1111/jgh.14128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
554 Reddy YK, Maliakkal B, Agbim U. Nutrition in Chronic Liver Disease. Curr Treat Options Gastro 2019;17:602-18. [DOI: 10.1007/s11938-019-00252-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
555 Cao G, Yi T, Liu Q, Wang M, Tang S. Alcohol consumption and risk of fatty liver disease: a meta-analysis. PeerJ 2016;4:e2633. [PMID: 27812428 DOI: 10.7717/peerj.2633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
556 Stice CP, Wang XD. Carotenoids and alcoholic liver disease. Hepatobiliary Surg Nutr 2013;2:244-7. [PMID: 24570953 DOI: 10.3978/j.issn.2304-3881.2013.10.01] [Reference Citation Analysis]
557 Li J, Liu C, Guo Y, Pi F, Yao W, Xie Y, Cheng Y, Qian H. Determination of the effects of torularhodin against alcoholic liver diseases by transcriptome analysis. Free Radical Biology and Medicine 2019;143:47-54. [DOI: 10.1016/j.freeradbiomed.2019.07.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
558 Palma E, Riva A, Moreno C, Odena G, Mudan S, Manyakin N, Miquel R, Degré D, Trepo E, Sancho-Bru P, Altamirano J, Caballeria J, Zamalloa A, Menon K, Heaton N, Williams R, Bataller R, Chokshi S. Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease. Alcohol Clin Exp Res 2020;44:856-65. [PMID: 32020641 DOI: 10.1111/acer.14299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
559 Rudler M, Thibault V, Mouri S, Akhavan S, Mallet M, Charlotte F, Poynard T, Thabut D. Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening? Eur J Gastroenterol Hepatol 2015;27:1367-71. [PMID: 26308710 DOI: 10.1097/MEG.0000000000000459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
560 Forrest EH, Gleeson D. Is a liver biopsy necessary in alcoholic hepatitis? Journal of Hepatology 2012;56:1427-8. [DOI: 10.1016/j.jhep.2011.12.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
561 Shah VH. Managing alcoholic liver disease. Clin Mol Hepatol 2015;21:212-9. [PMID: 26523266 DOI: 10.3350/cmh.2015.21.3.212] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
562 Dowman JK, Armstrong MJ, Tomlinson JW, Newsome PN. Current therapeutic strategies in non-alcoholic fatty liver disease. Diabetes, Obesity and Metabolism 2011;13:692-702. [DOI: 10.1111/j.1463-1326.2011.01403.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
563 Lin LJ, Cao N, Zheng CQ, Lin Y, Wang DX, Jin Y. An epidemiological survey of prevalence of fatty liver disease in a general adult population in Shenyang. Shijie Huaren Xiaohua Zazhi 2013; 21(12): 1114-1119 [DOI: 10.11569/wcjd.v21.i12.1114] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
564 Tada T, Kumada T, Toyoda H, Kobayashi N, Sone Y, Oguri T, Kamiyama N. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction. AJR Am J Roentgenol. 2019;212:332-341. [PMID: 30476453 DOI: 10.2214/ajr.18.20123] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
565 Wang X, Luo J, Chen R, Zha X, Wang H. The effects of daily supplementation of Dendrobium huoshanense polysaccharide on ethanol-induced subacute liver injury in mice by proteomic analysis. Food Funct 2014;5:2020. [DOI: 10.1039/c3fo60629e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
566 Kohli R, Ratziu V, Fiel MI, Waldmann E, Wilson DP, Balwani M. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group. Mol Genet Metab 2020;129:59-66. [PMID: 31767214 DOI: 10.1016/j.ymgme.2019.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
567 Yang AM, Wen LL, Yang CS, Wang SC, Chen CS, Bair MJ. Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients. Kaohsiung J Med Sci 2014;30:291-8. [PMID: 24835349 DOI: 10.1016/j.kjms.2014.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
568 Pi A, Jiang K, Ding Q, Lai S, Yang W, Zhu J, Guo R, Fan Y, Chi L, Li S. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice. Front Pharmacol 2021;12:752148. [PMID: 34603062 DOI: 10.3389/fphar.2021.752148] [Reference Citation Analysis]
569 Addolorato G, Mirijello A, Leggio L, Ferrulli A, D'Angelo C, Vassallo G, Cossari A, Gasbarrini G, Landolfi R, Agnes S, Gasbarrini A; Gemelli OLT Group. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res 2013;37:1601-8. [PMID: 23578009 DOI: 10.1111/acer.12117] [Cited by in Crossref: 97] [Cited by in F6Publishing: 78] [Article Influence: 10.8] [Reference Citation Analysis]
570 Deng J, Chen Z, Zhang X, Luo Y, Wu Z, Lu Y, Liu T, Zhao W, Lin B. A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells. Biomed Microdevices 2019;21. [DOI: 10.1007/s10544-019-0414-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
571 Kietzmann T. Liver Zonation in Health and Disease: Hypoxia and Hypoxia-Inducible Transcription Factors as Concert Masters. Int J Mol Sci 2019;20:E2347. [PMID: 31083568 DOI: 10.3390/ijms20092347] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
572 Wu T, Liu T, Zhang L, Xing LJ, Zheng PY, Ji G. Chinese medicinal formula, Qinggan Huoxue Recipe protects rats from alcoholic liver disease via the lipopolysaccharide-Kupffer cell signal conduction pathway. Exp Ther Med. 2014;8:363-370. [PMID: 25009584 DOI: 10.3892/etm.2014.1740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
573 Ambade A, Satishchandran A, Gyongyosi B, Lowe P, Szabo G. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World J Gastroenterol 2016; 22(16): 4091-4108 [PMID: 27122661 DOI: 10.3748/wjg.v22.i16.4091] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
574 Yang SC, Chen JC, Tai WC, Wu CK, Lee CH, Wu KL, Chiu YC, Wang JH, Lu SN, Chuah SK. The influential roles of antibiotics prophylaxis in cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments. PLoS One. 2014;9:e96394. [PMID: 24788341 DOI: 10.1371/journal.pone.0096394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
575 Puri P, Xu J, Vihervaara T, Katainen R, Ekroos K, Daita K, Min HK, Joyce A, Mirshahi F, Tsukamoto H, Sanyal AJ. Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese. J Lipid Res 2016;57:1017-28. [PMID: 27020313 DOI: 10.1194/jlr.M066175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
576 Shafaghati L, Razaghi-Moghadam Z, Mohammadnejad J. A Systems Biology Approach to Understanding Alcoholic Liver Disease Molecular Mechanism: The Development of Static and Dynamic Models. Bull Math Biol 2017;79:2450-73. [PMID: 28849551 DOI: 10.1007/s11538-017-0336-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
577 Lieber SR, Rice JP, Lucey MR, Bataller R. Controversies in clinical trials for alcoholic hepatitis. J Hepatol 2018;68:586-92. [PMID: 28966126 DOI: 10.1016/j.jhep.2017.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
578 Oldfield BJ, Edelman EJ. Addressing Unhealthy Alcohol Use and the HIV Pre-exposure Prophylaxis Care Continuum in Primary Care: A Scoping Review. AIDS Behav 2021;25:1777-89. [PMID: 33219492 DOI: 10.1007/s10461-020-03107-6] [Reference Citation Analysis]
579 Tada T, Kumada T, Toyoda H, Sone Y, Takeshima K, Ogawa S, Goto T, Wakahata A, Nakashima M, Nakamuta M, Tanaka J. Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy. Aliment Pharmacol Ther. 2018;47:1012-1022. [PMID: 29424449 DOI: 10.1111/apt.14554] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
580 Yeluru A, Cuthbert JA, Casey L, Mitchell MC. Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to Treatment. Alcohol Clin Exp Res. 2016;40:246-255. [PMID: 26842243 DOI: 10.1111/acer.12956] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
581 Banu S, Srivastava S, Mohammed A, Kushawah G, Sowpati DT, Mishra RK. Tissue-specific transcriptome recovery on withdrawal from chronic alcohol exposure in zebrafish. Alcohol 2021;91:29-38. [PMID: 33038458 DOI: 10.1016/j.alcohol.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
582 Kumada T, Toyoda H, Yasuda S, Sone Y, Ogawa S, Takeshima K, Tada T, Ito T, Sumida Y, Tanaka J. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus. Clin Transl Gastroenterol 2021;12:e00337. [PMID: 33888672 DOI: 10.14309/ctg.0000000000000337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
583 Morabito V, Novelli S, Poli L, Ferretti G, Ruberto F, Pugliese F, Pretagostini R, Berloco PB, Rossi M. Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study. Transplant Proc. 2016;48:352-358. [PMID: 27109954 DOI: 10.1016/j.transproceed.2015.12.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
584 Shimizu Y, Peltzer N, Sevko A, Lafont E, Sarr A, Draberova H, Walczak H. The Linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis. Hepatology 2017;65:1963-78. [PMID: 28120397 DOI: 10.1002/hep.29074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
585 Barbero-becerra VJ, López-velázquez JA, Sánchez-valle V, Uribe M, Méndez-sánchez N. Alcohol effects on liver diseases: good or bad buddy? Annals of Hepatology 2012;11:944-8. [DOI: 10.1016/s1665-2681(19)31422-x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
586 Dong H, Hao L, Zhang W, Zhong W, Guo W, Yue R, Sun X, Zhou Z. Activation of AhR-NQO1 Signaling Pathway Protects Against Alcohol-Induced Liver Injury by Improving Redox Balance. Cell Mol Gastroenterol Hepatol 2021;12:793-811. [PMID: 34082111 DOI: 10.1016/j.jcmgh.2021.05.013] [Reference Citation Analysis]
587 de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. Journal of Hepatology 2012;56:S75-87. [DOI: 10.1016/s0168-8278(12)60009-9] [Cited by in Crossref: 363] [Cited by in F6Publishing: 201] [Article Influence: 36.3] [Reference Citation Analysis]
588 Reddy SS, Civan JM. From Child-Pugh to Model for End-Stage Liver Disease. Medical Clinics of North America 2016;100:449-64. [DOI: 10.1016/j.mcna.2015.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
589 Seitz HK, Mueller S, Hellerbrand C, Liangpunsakul S. Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). Hepatobiliary Surg Nutr 2015;4:147-51. [PMID: 26151054 DOI: 10.3978/j.issn.2304-3881.2014.12.01] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
590 Liu J. Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol 2014; 20(40): 14672-14685 [PMID: 25356030 DOI: 10.3748/wjg.v20.i40.14672] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
591 Sebastiani G, Ghali P, Wong P, Klein MB, Deschenes M, Myers RP. Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Can J Gastroenterol Hepatol 2014;28:23-30. [PMID: 24416739 DOI: 10.1155/2014/675409] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
592 Choi NG, DiNitto DM, Marti CN, Choi BY. Sociodemographic Characteristics and Health Status of Lifetime Abstainers, Ex-Drinkers, Bingers, and Nonbingers Among Baby Boomers and Older Adults. Subst Use Misuse 2016;51:637-48. [PMID: 27007029 DOI: 10.3109/10826084.2015.1133645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
593 Han MAT, Vipani A, Noureddin N, Ramirez K, Gornbein J, Saouaf R, Baniesh N, Cummings-John O, Okubote T, Setiawan VW, Rotman Y, Loomba R, Alkhouri N, Noureddin M. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. Liver Int 2020;40:2242-51. [PMID: 32652744 DOI: 10.1111/liv.14593] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
594 Fuster D, Sanvisens A, Bolao F, Rivas I, Tor J, Muga R. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol 2016; 8(31): 1295-1308 [PMID: 27872681 DOI: 10.4254/wjh.v8.i31.1295] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
595 Zeng X, Li X, Xu C, Jiang F, Mo Y, Fan X, Li Y, Jiang Y, Li D, Huang M, Bi H. Schisandra sphenanthera extract (Wuzhi Tablet) protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice. Acta Pharm Sin B 2017;7:583-92. [PMID: 28924552 DOI: 10.1016/j.apsb.2017.04.002] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
596 Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572-1585. [PMID: 21920463 DOI: 10.1053/j.gastro.2011.09.002] [Cited by in Crossref: 1046] [Cited by in F6Publishing: 1007] [Article Influence: 95.1] [Reference Citation Analysis]
597 Dongiovanni P, Rametta R, Meroni M, Valenti L. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target? Expert Rev Gastroenterol Hepatol 2016;10:229-42. [PMID: 26641143 DOI: 10.1586/17474124.2016.1110018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
598 Machado MV, Janeiro A, Miltenberger-miltenyi G, Cortez-pinto H. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis. European Journal of Gastroenterology & Hepatology 2014;26:438-43. [DOI: 10.1097/meg.0000000000000044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
599 Adejumo AC, Ajayi TO, Adegbala OM, Adejumo KL, Alliu S, Akinjero AM, Onyeakusi NE, Ojelabi O, Bukong TN. Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease. Liver Int 2018;38:1475-86. [DOI: 10.1111/liv.13696] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
600 Morgan TR. Corticosteroids can be used to treat alcoholic hepatitis after a recent upper gastrointestinal bleed. J Hepatol 2015;62:759-60. [PMID: 25543081 DOI: 10.1016/j.jhep.2014.12.021] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
601 Yan Y, Ren L, Liu Y, Liu L. Long non-coding RNA CRNDE as potential biomarkers facilitate inflammation and apoptosis in alcoholic liver disease. Aging (Albany NY) 2021;13:23233-44. [PMID: 34633988 DOI: 10.18632/aging.203614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
602 Powers J, Zhang H, Battrell L, Meadows GG, Trobridge GD. Establishment of an immunodeficient alcohol mouse model to study the effects of alcohol on human cells in vivo. J Stud Alcohol Drugs 2012;73:933-7. [PMID: 23036211 DOI: 10.15288/jsad.2012.73.933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
603 Ma D, Hu J, Xu W, Wang Y, Wang J, Li L, Wang S, Zhou H, Li Y, Liu L. Phosphoesterase complex modulates microflora and chronic inflammation in rats with alcoholic fatty liver disease. Life Sci 2020;262:118509. [PMID: 33010280 DOI: 10.1016/j.lfs.2020.118509] [Reference Citation Analysis]
604 Procino F, Misciagna G, Veronese N, Caruso MG, Chiloiro M, Cisternino AM, Notarnicola M, Bonfiglio C, Bruno I, Buongiorno C, Campanella A, Deflorio V, Franco I, Guerra R, Leone CM, Mirizzi A, Nitti A, Osella AR; MICOL GROUP. Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver Int 2019;39:187-96. [PMID: 30248233 DOI: 10.1111/liv.13970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
605 Obogwu MB, Akindele AJ, Adeyemi OO. Hepatoprotective and in vivo antioxidant activities of the hydroethanolic leaf extract of Mucuna pruriens (Fabaceae) in antitubercular drugs and alcohol models. Chin J Nat Med 2014;12:273-83. [PMID: 24863352 DOI: 10.1016/S1875-5364(14)60054-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
606 El-sisi AEE, Sokar SS, Shebl AM, Mohamed DZ. Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats. Biomedicine & Pharmacotherapy 2017;89:1196-206. [DOI: 10.1016/j.biopha.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
607 Lu C, Jiang Y, Zhang F, Shao J, Wu L, Wu X, Lian N, Chen L, Jin H, Chen Q, Lu Y, Zheng S. Tetramethylpyrazine prevents ethanol-induced hepatocyte injury via activation of nuclear factor erythroid 2-related factor 2. Life Sciences 2015;141:119-27. [DOI: 10.1016/j.lfs.2015.08.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
608 Jiang X, Zhou Y, Zhang Y, Tian D, Jiang S, Tang Y. Hepatoprotective effect of pyrroloquinoline quinone against alcoholic liver injury through activating Nrf2-mediated antioxidant and inhibiting TLR4-mediated inflammation responses. Process Biochemistry 2020;92:303-12. [DOI: 10.1016/j.procbio.2020.01.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
609 Singal AK, Kamath PS. Model for End-stage Liver Disease. J Clin Exp Hepatol. 2013;3:50-60. [PMID: 25755471 DOI: 10.1016/j.jceh.2012.11.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
610 Li X, Jin Q, Zhang Y, Wu YL, Jin CM, Cui BW, Li Y, Jin MJ, Shang Y, Jiang M, Yang HX, Wu M, Liu J, Lian LH, Nan JX. Inhibition of P2X7R-NLRP3 Inflammasome Activation by Pleurotus citrinopileatus: A Possible Protective Role in Alcoholic Hepatosteatosis. J Agric Food Chem 2018;66:13183-90. [PMID: 30497264 DOI: 10.1021/acs.jafc.8b05756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
611 Chung W, Wang J, Bose S, Park J, Park S, Lee S, Jeon S, Kim H. Hepatoprotective Effect of Lentinus edodes Mycelia Fermented Formulation against Alcoholic Liver Injury in Rats: Hepatoprotective Effect of Fermented Formulation. Journal of Food Biochemistry 2015;39:251-62. [DOI: 10.1111/jfbc.12124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
612 Giunchedi P, Maestri M, Gavini E, Dionigi P, Rassu G. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1. Expert Opin Drug Deliv 2013;10:679-90. [PMID: 23406440 DOI: 10.1517/17425247.2013.770733] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
613 Fuster D, Sanvisens A, Bolao F, Serra I, Rivas I, Tor J, Muga R. Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. J Viral Hepat. 2015;22:18-24. [PMID: 25131721 DOI: 10.1111/jvh.12290] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
614 Sun P, Zhou X, Farnworth SL, Patel AH, Hay DC. Modeling human liver biology using stem cell-derived hepatocytes. Int J Mol Sci 2013;14:22011-21. [PMID: 24201130 DOI: 10.3390/ijms141122011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
615 He L, Deng T, Luo H. Aldehyde Dehydrogenase 2 (ALDH2) Polymorphism and the Risk of Alcoholic Liver Cirrhosis among East Asians: A Meta-Analysis. Yonsei Med J. 2016;57:879-884. [PMID: 27189280 DOI: 10.3349/ymj.2016.57.4.879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
616 Nguyen-khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. The Lancet Gastroenterology & Hepatology 2018;3:614-25. [DOI: 10.1016/s2468-1253(18)30124-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
617 Feng R, Chen JH, Liu CH, Xia FB, Xiao Z, Zhang X, Wan JB. A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice. Phytomedicine 2019;58:152824. [PMID: 30836218 DOI: 10.1016/j.phymed.2019.152824] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
618 Wu T, Morgan TR, Klein AS, Volk ML, Saab S, Sundaram V. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol 2018;17:759-68. [PMID: 30145578 DOI: 10.5604/01.3001.0012.3134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
619 Neuman MG, Seitz HK, French SW, Malnick S, Tsukamoto H, Cohen LB, Hoffman P, Tabakoff B, Fasullo M, Nagy LE, Tuma PL, Schnabl B, Mueller S, Groebner JL, Barbara FA, Yue J, Nikko A, Alejandro M, Brittany T, Edward V, Harrall K, Saba L, Mihai O. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research. Biomedicines 2020;8:E63. [PMID: 32197424 DOI: 10.3390/biomedicines8030063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
620 Kim TH, Um SH, Lee YS, Yim SY, Jung YK, Seo YS, Kim JH, An H, Yim HJ, Yeon JE, Byun KS. Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy. Aliment Pharmacol Ther 2022;55:83-96. [PMID: 34662436 DOI: 10.1111/apt.16658] [Reference Citation Analysis]
621 Peeraphatdit TB, Ahn JC, Choi DH, Allen AM, Simonetto DA, Kamath PS, Shah VH. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Mayo Clin Proc 2020;95:2612-20. [PMID: 33276835 DOI: 10.1016/j.mayocp.2020.04.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
622 Kim HY, Kim CW, Kim TY, Song DS, Sinn DH, Yoon EL, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Kim YS, Kim SG, Yang JM, Sohn JH, Lee HJ, Park SH, Choi EH, Kim DJ, Korean Acute-on-Chronic Liver Failure Study Group. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis. World J Gastroenterol 2016; 22(41): 9205-9213 [PMID: 27895407 DOI: 10.3748/wjg.v22.i41.9205] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
623 Wang JH, Meng QH. Malnutrition in alcoholic cirrhosis patients. Shijie Huaren Xiaohua Zazhi 2016; 24(15): 2298-2303 [DOI: 10.11569/wcjd.v24.i15.2298] [Reference Citation Analysis]
624 Testino G, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, Castiglione AG, Patussi V, Fanucchi T, Ancarani O, Cerce GD, Iannini AT, Greco G, Mosti A, Durante M, Babocci P, Quartini M, Mioni D, Aricò S, Baselice A, Leone S, Lozer F, Scafato E, Borro P. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement. World J Gastroenterol 2014; 20(40): 14642-14651 [PMID: 25356027 DOI: 10.3748/wjg.v20.i40.14642] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
625 Carr RM, Ahima RS. Pathophysiology of lipid droplet proteins in liver diseases. Exp Cell Res 2016;340:187-92. [PMID: 26515554 DOI: 10.1016/j.yexcr.2015.10.021] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 9.6] [Reference Citation Analysis]
626 Tada T, Kumada T, Toyoda H, Ohisa M, Akita T, Tanaka J. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model. J Gastroenterol 2018;53:1196-205. [PMID: 29675604 DOI: 10.1007/s00535-018-1467-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
627 Patel S, Behara R, Swanson GR, Forsyth CB, Voigt RM, Keshavarzian A. Alcohol and the Intestine. Biomolecules 2015;5:2573-88. [PMID: 26501334 DOI: 10.3390/biom5042573] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
628 Roman S, Zepeda-Carrillo EA, Moreno-Luna LE, Panduro A. Alcoholism and liver disease in Mexico: Genetic and environmental factors. World J Gastroenterol 2013; 19(44): 7972-7982 [PMID: 24307790 DOI: 10.3748/wjg.v19.i44.7972] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
629 DiMartini A, Crone C, Dew MA. Alcohol and substance use in liver transplant patients. Clin Liver Dis. 2011;15:727-751. [PMID: 22032526 DOI: 10.1016/j.cld.2011.08.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
630 Xie M, Rao W, Yang T, Deng Y, Zheng H, Pan C, Liu Y, Shen Z, Jia J. Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation. Liver Int. 2015;35:897-904. [PMID: 24750566 DOI: 10.1111/liv.12567] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
631 Huang YW, Yang SS, Kao JH. Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med 2011;3:1-11. [PMID: 24367215 DOI: 10.2147/HMER.S10265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
632 Fujiwara N, Trépo E, Raman I, Li QZ, Degré D, Gustot T, Moreno C, Hoshida Y. Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00220-2. [PMID: 33667676 DOI: 10.1016/j.cgh.2021.02.041] [Reference Citation Analysis]
633 Lazo M, Bilal U, Mitchell MC, Potter J, Hernaez R, Clark JM. Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population. Clin Gastroenterol Hepatol 2021;19:2606-2614.e4. [PMID: 32882427 DOI: 10.1016/j.cgh.2020.08.054] [Reference Citation Analysis]
634 Sharma P, Arora A. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. Transl Gastroenterol Hepatol 2020;5:19. [PMID: 32258523 DOI: 10.21037/tgh.2019.10.02] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
635 Greuter T, Malhi H, Gores GJ, Shah VH. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2017;2:95354. [PMID: 28878132 DOI: 10.1172/jci.insight.95354] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
636 Son M, Moon JY, Park S, Cho M. Hepatoprotective effect of Hippocampus abdominalis hydrolysate. JABC 2016;59:265-71. [DOI: 10.3839/jabc.2016.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
637 Choi SS, Diehl AM. Alcoholic Liver Disease. Handbook of Liver Disease. Elsevier; 2018. pp. 109-20. [DOI: 10.1016/b978-0-323-47874-8.00008-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
638 Kim TH, Yun SG, Choi J, Goh HG, Lee HA, Yim SY, Choi SJ, Lee YS, Yoon EL, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Um SH. Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores. J Korean Med Sci 2020;35:e129. [PMID: 32419396 DOI: 10.3346/jkms.2020.35.e129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
639 Potts JR, Howard MR, Verma S. Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes. European Journal of Gastroenterology & Hepatology 2013;25:659-64. [DOI: 10.1097/meg.0b013e32835d83d9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
640 Pavlov CS, Casazza G, Nikolova D, Tsochatzis E, Gluud C. Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease. Aliment Pharmacol Ther. 2016;43:575-585. [PMID: 26791825 DOI: 10.1111/apt.13524] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
641 Ramirez T, Longato L, Dostalek M, Tong M, Wands JR, de la Monte SM. Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis. Alcohol Alcohol 2013;48:39-52. [PMID: 22997409 DOI: 10.1093/alcalc/ags106] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
642 Donohue TM, Osna NA, Trambly CS, Whitaker NP, Thomes PG, Todero SL, Davis JS. Early growth response-1 contributes to steatosis development after acute ethanol administration. Alcohol Clin Exp Res. 2012;36:759-767. [PMID: 22141421 DOI: 10.1111/j.1530-0277.2011.01681.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
643 Woo GA, O'Brien C. Long-term management of alcoholic liver disease. Clin Liver Dis 2012;16:763-81. [PMID: 23101981 DOI: 10.1016/j.cld.2012.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
644 Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B. Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol. 2016;13:206-216. [PMID: 25661730 DOI: 10.1038/cmi.2015.06] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
645 An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch Toxicol. 2012;86:1337-1348. [PMID: 22367091 DOI: 10.1007/s00204-012-0814-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 7.8] [Reference Citation Analysis]
646 Hsu CC, Kowdley KV. The Effects of Alcohol on Other Chronic Liver Diseases. Clin Liver Dis. 2016;20:581-594. [PMID: 27373618 DOI: 10.1016/j.cld.2016.02.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
647 Choudhary NS, Kumar N, Saigal S, Rai R, Saraf N, Soin AS. Liver Transplantation for Alcohol-Related Liver Disease. J Clin Exp Hepatol 2016;6:47-53. [PMID: 27194896 DOI: 10.1016/j.jceh.2016.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
648 Hardy T, Wells C, Kendrick S, Hudson M, Day CP, Burt AD, Masson S, Stewart SF. White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterol 2013;13:55. [PMID: 23530737 DOI: 10.1186/1471-230X-13-55] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
649 Yi X, Long L, Yang C, Lu Y, Cheng M. Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice. PLoS One 2014;9:e93599. [PMID: 24690765 DOI: 10.1371/journal.pone.0093599] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
650 Jia Q, Li C, Xia Y, Zhang Q, Wu H, Du H, Liu L, Wang C, Shi H, Guo X, Liu X, Sun S, Wang X, Zhou M, Zhao H, Song K, Wu Y, Niu K. Association between complement C3 and prevalence of fatty liver disease in an adult population: a cross-sectional study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) cohort study. PLoS One 2015;10:e0122026. [PMID: 25856141 DOI: 10.1371/journal.pone.0122026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
651 Nikolova-Karakashian M. Alcoholic and non-alcoholic fatty liver disease: Focus on ceramide. Adv Biol Regul. 2018;70:40-50. [PMID: 30455063 DOI: 10.1016/j.jbior.2018.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
652 Kim HY, Chang Y, Park JY, Ahn H, Cho H, Han SJ, Oh S, Kim D, Jung YJ, Kim BG, Lee KL, Kim W. Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism: Alcoholic acute-on-chronic liver failure. Journal of Gastroenterology and Hepatology 2016;31:427-33. [DOI: 10.1111/jgh.13084] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
653 Albano E. Oxidative Stress in Alcoholic Liver Disease. In: Albano E, Parola M, editors. Studies on Hepatic Disorders. Cham: Springer International Publishing; 2015. pp. 215-39. [DOI: 10.1007/978-3-319-15539-5_10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
654 Nagappan A, Jung DY, Kim JH, Lee H, Jung MH. Gomisin N Alleviates Ethanol-Induced Liver Injury through Ameliorating Lipid Metabolism and Oxidative Stress. Int J Mol Sci 2018;19:E2601. [PMID: 30200508 DOI: 10.3390/ijms19092601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
655 Kim A, Mccullough RL, Poulsen KL, Sanz-garcia C, Sheehan M, Stavitsky AB, Nagy LE. Hepatic Immune System: Adaptations to Alcohol. In: Grant KA, Lovinger DM, editors. The Neuropharmacology of Alcohol. Cham: Springer International Publishing; 2018. pp. 347-67. [DOI: 10.1007/164_2017_88] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
656 Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2013;28 Suppl 1:11-17. [PMID: 23855290 DOI: 10.1111/jgh.12036] [Cited by in Crossref: 154] [Cited by in F6Publishing: 166] [Article Influence: 19.3] [Reference Citation Analysis]
657 Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol 2017;66:195-211. [PMID: 27575312 DOI: 10.1016/j.jhep.2016.08.011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
658 Cadranel JD, Nousbaum J, Gouillou M, Hanslik B. Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France: . European Journal of Gastroenterology & Hepatology 2016;28:e26-32. [DOI: 10.1097/meg.0000000000000683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
659 Ohashi K, Pimienta M, Seki E. Alcoholic liver disease: A current molecular and clinical perspective. Liver Res. 2018;2:161-172. [PMID: 31214376 DOI: 10.1016/j.livres.2018.11.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
660 de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci 2015;16:30269-308. [PMID: 26694382 DOI: 10.3390/ijms161226225] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 16.4] [Reference Citation Analysis]
661 Latchoumycandane C, Nagy LE, McIntyre TM. Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation. Free Radic Biol Med 2014;69:403-16. [PMID: 24412858 DOI: 10.1016/j.freeradbiomed.2014.01.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
662 Reyes-gordillo K, Shah R, Lakshman M, Flores-beltrán R, Muriel P. Hepatoprotective Properties of Curcumin. Liver Pathophysiology. Elsevier; 2017. pp. 687-704. [DOI: 10.1016/b978-0-12-804274-8.00049-7] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
663 Sahlman P, Nissinen M, Pukkala E, Färkkilä M. Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study. Scandinavian Journal of Gastroenterology 2016;51:961-6. [DOI: 10.3109/00365521.2016.1157889] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
664 Cho YE, Song BJ, Akbar M, Baek MC. Extracellular vesicles as potential biomarkers for alcohol- and drug-induced liver injury and their therapeutic applications. Pharmacol Ther. 2018;187:180-194. [PMID: 29621595 DOI: 10.1016/j.pharmthera.2018.03.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
665 Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-bismut F, Ratziu V, Hartemann-huertier A, Housset C, Poynard T; the FLIP Consortium. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. Aliment Pharmacol Ther 2014;40:1081-93. [DOI: 10.1111/apt.12946] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
666 Stickel F, Seitz HK. Alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol. 2010;24:683-693. [PMID: 20955970 DOI: 10.1016/j.bpg.2010.07.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
667 Li YM, Fan JG; National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Disease Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease (2018, China). J Dig Dis 2019;20:174-80. [PMID: 30450822 DOI: 10.1111/1751-2980.12687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
668 Mitchell MC, Friedman LS, McClain CJ. Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol 2017;15:5-12. [PMID: 27979049 DOI: 10.1016/j.cgh.2016.08.047] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 9.6] [Reference Citation Analysis]
669 Shen M, Shen Y, Fan X, Men R, Ye T, Yang L. Roles of Macrophages and Exosomes in Liver Diseases. Front Med (Lausanne) 2020;7:583691. [PMID: 33072790 DOI: 10.3389/fmed.2020.583691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
670 Kadian M, Kakkar R, Dhar M, Kaushik RM. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis. J Gastroenterol Hepatol. 2014;29:581-588. [PMID: 24117536 DOI: 10.1111/jgh.12400] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
671 Gao F, Gao R, Li G, Shang ZM, Hao JY. Health-related quality of life and survival in Chinese patients with chronic liver disease. Health Qual Life Outcomes 2013;11:131. [PMID: 23902894 DOI: 10.1186/1477-7525-11-131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
672 Chi ZC. Intestinal barrier dysfunction and alcoholic liver disease. Shijie Huaren Xiaohua Zazhi 2019; 27(19): 1179-1192 [DOI: 10.11569/wcjd.v27.i19.1179] [Reference Citation Analysis]
673 Miller AM, Wang H, Bertola A, Park O, Horiguchi N, Ki SH, Yin S, Lafdil F, Gao B. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. Hepatology. 2011;54:846-856. [PMID: 21725996 DOI: 10.1002/hep.24517] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 10.6] [Reference Citation Analysis]
674 Sakhuja P. Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis? World J Gastroenterol 2014; 20(44): 16474-16479 [PMID: 25469015 DOI: 10.3748/wjg.v20.i44.16474] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
675 Reddavide R, Cisternino AM, Inguaggiato R, Rotolo O, Zinzi I, Veronese N, Guerra V, Fucilli F, Di Giovanni G, Leandro G, Giannico S, Caruso MG. Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. Nutrients 2019;11:E1830. [PMID: 31394881 DOI: 10.3390/nu11081830] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
676 Lemasters JJ, Holmuhamedov EL, Czerny C, Zhong Z, Maldonado EN. Regulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effect. Biochim Biophys Acta. 2012;1818:1536-1544. [PMID: 22172804 DOI: 10.1016/j.bbamem.2011.11.034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
677 Li YM, Fan JG, Wang BY, Lu LG, Shi JP, Niu JQ, Shen W; Chinese Association for the Study of Liver Disease. Guidelines for the diagnosis and management of alcoholic liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 167-170). J Dig Dis. 2011;12:45-50. [PMID: 21276208 DOI: 10.1111/j.1751-2980.2010.00477.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
678 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
679 Canha MI, Oliveiros B, Franco C, Figueiredo P. The lifestyle influence on alcoholic pancreatitis versus alcoholic liver disease: a case-control study. Scand J Gastroenterol 2017;52:1278-85. [PMID: 28830264 DOI: 10.1080/00365521.2017.1365167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
680 Zabala V, Tong M, Yu R, Ramirez T, Yalcin EB, Balbo S, Silbermann E, Deochand C, Nunez K, Hecht S. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease. Alcohol Alcohol. 2015;50:118-131. [PMID: 25618784 DOI: 10.1093/alcalc/agu083] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
681 de la Monte SM, Tong M, Agarwal AR, Cadenas E. Tobacco Smoke-Induced Hepatic Injury with Steatosis, Inflammation, and Impairments in Insulin and Insulin-Like Growth Factor Signaling. J Clin Exp Pathol 2016;6:269. [PMID: 27525191 DOI: 10.4172/2161-0681.1000269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
682 Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC. Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress. Redox Biol 2014;3:100-8. [PMID: 25453982 DOI: 10.1016/j.redox.2014.09.005] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
683 Hirayama Y, Daniels NF, Evans S, Clarke D, Purvis S, Oliver C, Woodmansey S, Staniforth J, Soilleux EJ. High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor? Diagnostics (Basel) 2021;11:1703. [PMID: 34574044 DOI: 10.3390/diagnostics11091703] [Reference Citation Analysis]
684 Xu Q, Xi H, Chen X, Xu Y, Wang P, Li J, Wei W, Gu F, Qin Y. Milk‑derived hexapeptide PGPIPN prevents and attenuates acute alcoholic liver injury in mice by reducing endoplasmic reticulum stress. Int J Mol Med 2020;46:1107-17. [PMID: 32705158 DOI: 10.3892/ijmm.2020.4643] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
685 Lauwens S, Costas-Rodríguez M, Delanghe J, Van Vlierberghe H, Vanhaecke F. Quantification and isotopic analysis of bulk and of exchangeable and ultrafiltrable serum copper in healthy and alcoholic cirrhosis subjects. Talanta 2018;189:332-8. [PMID: 30086927 DOI: 10.1016/j.talanta.2018.07.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
686 Zhang F, Zhang J, Li Y. Corn oligopeptides protect against early alcoholic liver injury in rats. Food and Chemical Toxicology 2012;50:2149-54. [DOI: 10.1016/j.fct.2012.03.083] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
687 Thursz M, Forrest E, Roderick P, Day C, Austin A, O’Grady J, Ryder S, Allison M, Gleeson D, McCune A. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. Health Technol Assess. 2015;19:1-104. [PMID: 26691209 DOI: 10.3310/hta191020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
688 Gu Z, Wu Y, Wang Y, Sun H, You Y, Piao C, Liu J. Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury.J Med Food. 2020;23:114-124. [PMID: 31747353 DOI: 10.1089/jmf.2018.4357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
689 Donohue TM Jr, Thomes PG. Ethanol-induced oxidant stress modulates hepatic autophagy and proteasome activity. Redox Biol 2014;3:29-39. [PMID: 25462063 DOI: